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Abstract The mitochondrion of apicomplexan parasites is critical for parasite survival, although
the full complement of proteins that localize to this organelle has not been defined. Here we
undertake two independent approaches to elucidate the mitochondrial proteome of the
apicomplexan Toxoplasma gondii. We identify approximately 400 mitochondrial proteins, many of
which lack homologs in the animals that these parasites infect, and most of which are important for
parasite growth. We demonstrate that one such protein, termed TgApiCox25, is an important
component of the parasite cytochrome c oxidase (COX) complex. We identify numerous other
apicomplexan-specific components of COX, and conclude that apicomplexan COX, and
apicomplexan mitochondria more generally, differ substantially in their protein composition from
the hosts they infect. Our study highlights the diversity that exists in mitochondrial proteomes
across the eukaryotic domain of life, and provides a foundation for defining unique aspects of
mitochondrial biology in an important phylum of parasites.
DOI: https://doi.org/10.7554/eLife.38131.001
Introduction
Mitochondria were derived from a-proteobacteria in an endosymbiotic event, and were present in
the last common ancestor of all eukaryotes (Gray, 2012; Sagan, 1967). Mitochondria and related
organelles are present in almost all extant eukaryotes. They function in the biosynthesis of molecules
such as iron-sulfur clusters, lipids, coenzyme Q, heme and amino acids, the catabolism of molecules
such as fatty acids, amino acids and monocarboxylates, the storage of ions and signalling molecules
such as Ca2+, the regulation of apoptosis, and the production of energy-carrying molecules such as
ATP and NADH (McBride et al., 2006; van Dooren et al., 2006; Zı´kova´ et al., 2016). Notably, the
function of mitochondria and related organelles vary substantially between different eukaryotic line-
ages, reflective of the >1500 M years that separate these lineages (Chernikova et al., 2011;
Zı´kova´ et al., 2016).
Apicomplexans are a phylum of intracellular parasites that impose a significant medical and eco-
nomic burden on human populations around the world. Apicomplexans include the causative agents
of malaria (Plasmodium spp.), cryptosporidiosis (Cryptosporidium spp.) and toxoplasmosis (Toxo-
plasma gondii). T. gondii is an opportunistic parasite that chronically infects approximately one-third
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of the world’s adult population. Symptoms of T. gondii infection in healthy individuals are typically
mild. In immunocompromised individuals and unborn fetuses, however, T. gondii infection can cause
severe neurological and developmental impairment, and, without treatment, can lead to death of
the infected individual (Montoya and Liesenfeld, 2004). The tractable genetics of T. gondii make it
a versatile model for studying conserved aspects of apicomplexan biology.
Mitochondria are critical for the survival of apicomplexans, and several important drugs target
proteins that function in this organelle, including atovaquone and endochin-like quinolones, both of
which target cytochrome c reductase (complex III) of the electron transport chain, and DSM1, which
targets dihydroorotate dehydrogenase, a central enzyme in pyrimidine biosynthesis (Doggett et al.,
2012; Phillips et al., 2008; Srivastava et al., 1999). The functions of apicomplexan mitochondria
are largely implied through comparative genomic approaches that have identified homologs of
genes encoding known mitochondrial proteins from other eukaryotes (Seeber et al., 2008;
van Dooren et al., 2006). The genome of apicomplexans such as T. gondii and Plasmodium spp.
encode homologs of proteins involved in core mitochondrial processes such as the electron trans-
port chain, the tricarboxylic acid (TCA) cycle, and the synthesis of molecules such as iron-sulfur clus-
ters, heme and coenzyme Q (Seeber et al., 2008; van Dooren et al., 2006). The mitosome of
Cryptosporidium parvum is highly reduced compared to that of other apicomplexans, lacking a TCA
cycle, and harboring a minimal electron transport chain, but retaining the capacity for iron-sulfur
cluster synthesis (Mogi and Kita, 2009).
Apicomplexans belong to a group of eukaryotes known as the myzozoans, that also include dino-
flagellates and chromerids (Cavalier-Smith and Chao, 2004). Chromerids are a phylum of free-living,
photosynthetic eukaryotes, and are thought to be the closest extant relatives of apicomplexans
(Moore et al., 2008). All known myzozoans retain a mitochondrion or mitochondrion-derived organ-
elle, the functions of which have numerous differences from well-studied eukaryotes such as yeast
and animals (Danne et al., 2013; Jacot et al., 2016). In addition to a limited gene content, the mito-
chondrial genomes of these organisms contain unusually fragmented ribosomal RNAs (Feagin et al.,
2012). Myzozoan mitochondria lack pyruvate dehydrogenase, the enzyme complex that decarboxy-
lates pyruvate to form acetyl-CoA (Danne et al., 2013; Foth et al., 2005). Instead, these organisms
have repurposed a branched-chain a-ketoacid dehydrogenase (BCKDH) to catalyse this reaction
(Oppenheim et al., 2014). Myzozoans have a functional TCA cycle, but some enzymes of this path-
way are phylogenetically distinct from equivalent enzymes in yeast and humans (Danne et al., 2013;
Ke et al., 2015; MacRae et al., 2013; MacRae et al., 2012; van Dooren et al., 2006). These organ-
isms also contain a mitochondrial ATP synthase that lacks clear homologs to many of the proteins
that comprise the membrane-bound F0 component of the complex (Balabaskaran Nina et al., 2011;
Sturm et al., 2015).
Elucidating the proteomes of mitochondria is key to understanding their functions. Organellar
proteomics in intracellular parasites such as T. gondii is limited by available material and a lack of
established organellar purification techniques. To overcome these obstacles, we adopted two com-
plementary spatially-restricted biotin tagging approaches to define the proteome of the mitochon-
drial matrix of T. gondii. We identified over 400 putative mitochondrial matrix proteins, many of
which have no ascribed function and no clear homology to proteins found in well-characterised
eukaryotes such as yeast, and most of which are important for parasite growth and survival. We func-
tionally characterise one protein that had no previously ascribed function, and demonstrate that this
is a critical component of the cytochrome c oxidase (COX) complex of the mitochondrial electron
transport chain in the parasite. We subsequently identify numerous apicomplexan-specific compo-
nents of COX. These data reveal considerable divergence in the COX complex, and in mitochondria
more generally, of T. gondii and related apicomplexans, compared to the animals they infect.
Results
Spatially-restricted biotinylation of mitochondrial matrix proteins
A genetically modified plant ascorbate peroxidase (APEX) was recently developed as a tool for bioti-
nylating proximal proteins in mammalian cells (Hung et al., 2014; Rhee et al., 2013). This technique
was used to define the proteome of the matrix and inter-membrane space of mammalian mitochon-
dria. An alternative spatial biotinylation approach involves the use of a genetically modified,
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promiscuous biotin protein ligase (BirA*), an approach that is typically utilised to elucidate protein-
protein interactions (Roux et al., 2012). We sought to utilize APEX and BirA* to map the mitochon-
drial matrix proteome of T. gondii.
We generated parasite strains expressing APEX or BirA* fused at their N-termini to the mitochon-
drial matrix-targeting sequence of TgHsp60 (van Dooren et al., 2009). Immunofluorescence assays
demonstrated that both mitochondrially-targeted APEX (mtAPEX) and mitochondrially-targeted
Figure 1. Biotinylation of mitochondrial matrix proteins in T.gondii parasites expressing mtAPEX and mtBirA*.T (A–B) Immunofluorescence assays of
parasites expressing c-myc-tagged, mitochondrially-targeted APEX (A) and BirA* (B), labelled with anti-c-myc (green) and the mitochondrial marker
TgTom40 (red). Scale bars are 2 mm. (C–D) Western blots of parasites expressing c-myc-tagged, mitochondrially-targeted APEX (C) and BirA* (D),
labelled with anti-c-myc. (E) Oregon Green-conjugated avidin (Avidin-OG) labelling of T. gondii parasites expressing mtAPEX, and cultured in the
absence (top) or presence (bottom) of biotin-phenol and H2O2. Biotinylated proteins are labelled in green. (F) Avidin-OG labelling of T. gondii parasites
expressing mtBirA*, and cultured in the absence (top) or presence (bottom) of biotin. Biotinylated proteins are labelled in green. Scale bars are 2 mm.
(G) Neutravidin-HRP protein blot of WT, mtBirA* or mtAPEX parasites cultured in the presence of biotin or biotin-phenol. (H) Western blots of the
mitochondrial matrix marker mtHsp60 and the mitochondrial intermembrane space marker cyt c in WT, mtBirA* or mtAPEX parasites cultured in the
presence of biotin (lanes 1 – 4) or biotin-phenol (lanes 5 – 8). Parasites were either harvested following treatment to yield the total (T) protein fraction,
or biotinylated proteins were purified on a streptavidin-agarose column to yield the bound (B) fraction.
DOI: https://doi.org/10.7554/eLife.38131.002
The following figure supplement is available for figure 1:
Figure supplement 1. Map of the pBTM3 plasmid vector, showing the AvrII, NdeI and NotI cut sites between which the APEX and BirA* cassettes were
ligated (open reading frame of enzyme shown in green), the position of mitochondrial targeting leader sequence of TgHsp60 (Hsp60L; red), the 3x
c-myc tag (yellow), and the positions of the phleomycin resistance marker (PhlR) for T.gondii selection, the ampicillin resistance marker for E. coli
selection (AmpR), and the origin of replication (Ori; all magenta).
DOI: https://doi.org/10.7554/eLife.38131.003
Seidi et al. eLife 2018;7:e38131. DOI: https://doi.org/10.7554/eLife.38131 3 of 36
Research article Microbiology and Infectious Disease
BirA* (mtBirA*) co-localised with TgTom40, a marker for the T. gondii mitochondrion (Figure 1A–B;
van Dooren et al., 2016). Western blots confirmed the presence of mtAPEX and mtBirA* proteins
of the expected mass (Figure 1C–D).
To determine whether mtAPEX could label mitochondrial proteins, we treated parasites with bio-
tin-phenol for 1 hr, initiated biotinylation by adding H2O2 for 1 min, then fixed and labelled parasites
with Oregon green-conjugated avidin, a specific stain for biotinylated proteins. We observed mito-
chondrial labelling in treated parasites, and not in untreated parasites (Figure 1E), consistent with
mtAPEX mediating the biotinylation of mitochondrial proteins. In untreated parasites, we observed
labelling of endogenously biotinylated proteins in the apicoplast, consistent with previous observa-
tions (Figure 1E; Chen et al., 2015; Jelenska et al., 2001).
To determine whether mtBirA* could label mitochondrial proteins, we incubated mtBirA*-
expressing parasites in medium supplemented with 1 mM biotin for 1 day. We labelled parasites
with Oregon green-conjugated avidin and observed labelling in the mitochondrion of biotin-supple-
mented parasites, but not in untreated parasites (Figure 1F).
To observe the extent of protein biotinylation in the treated mtAPEX and mtBirA* parasites, we
extracted proteins from RH strain wild type (WT), mtAPEX or mtBirA* parasites treated with either
biotin-phenol and H2O2 or with biotin. We separated these by SDS-PAGE and probed with horse
radish peroxidase (HRP)-conjugated neutravidin to label biotinylated proteins. In WT cells, we
observed two major bands of the expected sizes of natively biotinylated proteins in these parasites
(Figure 1G; van Dooren et al., 2008). In the biotin-phenol treated mtAPEX parasites, we observed
labelling of several additional proteins, whereas in biotin-supplemented mtBirA* parasites, numerous
proteins were labelled (Figure 1G). These data indicate that mtAPEX- and mtBirA*-mediated bioti-
nylation is occurring in these parasites.
To determine the specificity of labelling, we extracted proteins from treated WT, mtAPEX and
mtBirA* parasites and subjected these to affinity purification using streptavidin-conjugated magnetic
beads. We separated purified proteins by SDS-PAGE and probed with antibodies against TgHsp60
(mtHsp60), a mitochondrial matrix marker (Toursel et al., 2000; van Dooren et al., 2016), and
against T. gondii cytochrome c (cyt c), a mitochondrial intermembrane space marker (E.T. and G.v.
D., unpublished). We did not detect mtHsp60 or cyt c in the streptavidin bound fraction in WT para-
sites treated with biotin-phenol and H2O2, or with biotin (Figure 1H). We detected bound mtHsp60,
but not bound cyt c, in proteins extracted from both biotin-phenol-treated mtAPEX and biotin-
treated mtBirA* parasites. This is consistent with the mitochondrial labelling that we observe being
specific for the mitochondrial matrix.
Quantitative proteomics to elucidate the mitochondrial matrix
proteome
Having established two independent approaches for specifically labelling mitochondrial matrix pro-
teins, we next undertook a label-free quantitative proteomic analysis of biotinylated proteins in
treated mtAPEX and mtBirA* parasites. First, we generated three independent cell lysate pools of
WT and mtAPEX cells treated with biotin-phenol and H2O2, and WT and mtBirA* cells treated with
biotin. Biotinylated proteins were purified from these lysates using streptavidin beads, reduced, alky-
lated, and trypsin-digested before being identified using mass spectrometry (MS). Triplicate samples
were then processed through our in-house quantitation pipeline to determine the relative abun-
dance of each protein identified in the mtAPEX or mtBirA* samples as compared to WT controls.
These data are represented on a volcano plot as a fold-change (log2 value) vs significance of the
change (–log10 p value) (Figure 2A–B). This revealed an enrichment of numerous proteins in the
mtAPEX and mtBirA* samples. Using cut-offs of p<0.001 and a WT:mtAPEX/mtBirA* log2 fold
change of  2.5, 421 proteins were identified in total: 213 proteins in the APEX samples and 369
proteins in the mtBirA* samples, with 161 proteins common to both proteomes (Figure 2C;
Supplementary file 1). Hereafter, we refer to the list of 421 proteins as the mitochondrial proteome
of T. gondii.
Bioinformatic characterisation of the mitochondrial proteome
To test the validity of the T. gondii mitochondrial proteome, we undertook a series of in silico and
experimental analyses. Proteins targeted to the mitochondrial matrix typically harbor an N-terminal
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amphipathic a-helix that facilitates import into the organelle (van Dooren et al., 2016). We exam-
ined the T. gondii mitochondrial proteome for proteins predicted to contain such an N-terminal tar-
geting domain using the rules-based computational prediction tool MitoProt II (Claros and Vincens,
1996). Approximately 40% of proteins in the proteome had a strongly predicted N-terminal target-
ing sequences (probability of mitochondrial import >0.9), and a further ~20% had a moderately pre-
dicted targeting sequence (probability of import 0.5 – 0.9; Figure 2—figure supplement 1;
Supplementary file 1). A further ~40% had a low probability of mitochondrial import (probability of
import <0.5; Figure 2—figure supplement 1). This suggests that either the mitochondrial proteome
has many false positives, or that many T. gondii mitochondrial proteins lack N-terminal targeting
sequences, or that mitochondrial prediction tools such as MitoProt II are not suitable for analysis of
mitochondrial proteins from T. gondii. Notably in this regard, the dataset used to develop MitoProt
II did not include T. gondii proteins (Claros and Vincens, 1996).
Figure 2. The mitochondrial proteome of T.gondii. (A–B) Volcano plots showing the log2 protein ratios vs –log10 p values of biotinylated proteins in
WT compared to mtAPEX (WT/APEX) samples (A) and in WT compared to mtBirA* samples (WT/BirA*) (B) following the quantitative pipeline analysis.
Proteins were deemed to be enriched in the mitochondrion if the log2 fold change in protein expression was  2.5 and the p value  0.001 (red). (C)
Venn diagram of the mtAPEX and mtBirA* proteomes. 161 proteins were identified in both proteomes, while 52 were unique to the mtAPEX proteome
and 208 unique to the mtBirA* proteome. (D) Metabolic map of expected mitochondrial proteins (circles), showing proteins present (blue) and absent
(yellow) from the T. gondii mitochondrial proteome. Black arrows represent the flow of metabolites through metabolic pathways in the mitochondrion,
and blue arrows depict the flow of ions, minerals or metabolic pathway products.
DOI: https://doi.org/10.7554/eLife.38131.004
The following figure supplement is available for figure 2:
Figure supplement 1. Analysis of putative mitochondrial targeting peptides in the T.gondii mitochondrial proteome.
DOI: https://doi.org/10.7554/eLife.38131.005
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Next, we examined metabolic pathway enrichment of the mitochondrial proteome (http://tox-
odb.org; Gajria et al., 2008; p value cutoff < 0.05; Supplementary file 2). We observed the great-
est enrichment in proteins involved in the TCA cycle, oxidative phosphorylation, and pyruvate
metabolism, all processes predicted to occur in the mitochondrion. We observed enrichment of
other processes predicted to occur in the mitochondrion, including ubiquinone biosynthesis, one
carbon metabolism, and branched chain amino acid degradation. We also observed enrichment of
some processes not expected to occur in the mitochondrion, such as glycolysis/gluconeogenesis,
suggesting the presence of some false positives in our proteome.
To analyse the mitochondrial proteome in greater detail, we mapped proteins to previously con-
structed metabolic maps of apicomplexan mitochondria (Supplementary file 3; Seeber et al., 2008;
van Dooren et al., 2006). This analysis identified all subunits of the BCKDH, all enzymes of the TCA
cycle, all proteins predicted to function in mitochondrial Fe-S cluster synthesis, four of the seven
enzymes predicted to function in coenzyme Q synthesis, and two of the three mitochondrial proteins
involved in heme synthesis (Figure 2D). Additionally, we identified all five ubiquinone-reducing
dehydrogenases of the mitochondrial inner membrane, and all currently predicted subunits of cyto-
chrome c reductase (Complex III) and cytochrome c oxidase (Complex IV) that are encoded on the
nuclear genome (Figure 2D). We were unable to identify cytochrome b, CoxI and CoxIII, proteins
encoded on the mitochondrial genome of apicomplexan parasites. This is a surprising result. These
proteins are all highly hydrophobic, and deeply embedded in the mitochondrial inner membrane as
part of protein complexes. They may, therefore, not be accessible to biotinylation from the mito-
chondrial matrix. Alternatively, it is possible that due to the hydrophobic nature of these proteins,
they were not available for enzymatic digestion, and thus failed to be detected by mass spectromet-
ric analysis. A third possibility relates to the sequence of the mitochondrial genome in T. gondii,
which has not yet been verified. Copies of the mitochondrial genome have migrated into the T. gon-
dii nucleus, and (possibly pseudo) protein isoforms of these may have been included in the T. gondii
protein dataset we used in identification. It is conceivable, therefore, that the predicted amino acid
sequences of these do not match the sequence of the true proteins, which may have prevented their
detection in our approaches. As expected, we did not identify the two isoforms of cytochrome c,
both predicted to localize to the intermembrane space. We identified the a, b, g and d subunits of
the F1 component of ATP synthase, but not the e subunit.
We identified numerous other proteins shown previously to localise to the mitochondrion
(Supplementary file 3), including components of the presequence translocase associated motor
(van Dooren et al., 2016), the aforementioned TgHsp60 (Toursel et al., 2000), components of the
mitochondrial processing peptidase (van Dooren et al., 2016), a mitochondrial pyruvate kinase
(Saito et al., 2008), a component of the g aminobutyric acid shunt (MacRae et al., 2012), an
enzyme involved in phospholipid synthesis (Hartmann et al., 2014), and proteins associated with
DNA repair (Garrison and Arrizabalaga, 2009) and antioxidant defences (Brydges and Carruthers,
2003; Ding et al., 2004). Notably, we were unable to identify mitochondrially-localised enzymes
involved in the 2-methylcitrate cycle (Limenitakis et al., 2013). We identified several conserved sol-
ute transporter proteins, and numerous proteins with housekeeping roles in the mitochondrion,
including mitochondrial RNA polymerase, 18 ribosomal proteins (Gupta et al., 2014), ribosome mat-
uration factors, and various translation elongation factors (Supplementary file 3). A recent genome-
wide CRISPR-based screen to identify genes important for in vitro growth of tachyzoite-stage T. gon-
dii identified 15 so-called Indispensable Conserved Apicomplexan Proteins (ICAPs; Sidik et al.,
2016). Of these, eight localised to the mitochondrion. We identified 6 of these mitochondrial ICAPs
in the mitochondrial proteome. In total, our proteomics identified 97 out of 111 proteins that previ-
ous studies had experimentally localized, or predicted to localize, to the mitochondrion, suggesting
a high level of coverage (87%).
We analysed which of the 97 ‘true positive’ mitochondrial proteins were found in both pro-
teomes, and which were identified in the mtAPEX or mtBirA* proteomes alone (Supplementary file
3). We found that 54% of the 97 true positive proteins were identified in both proteomes, and that
19% and 28% were identified in only the mtAPEX or mtBirA* proteomes, respectively. We compared
these percentages to the overall percentages of proteins found in each dataset (Figure 2C). Nota-
bly, the 28% of ‘expected’ mitochondrial proteins identified in the mtBirA*-alone category is an
under-representation of the 49% (208/421) of proteins in this category overall (Figure 2C). This
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raises the possibility that proteins categorised in the mtBirA* proteome alone contain more false
positives than in the shared and mtAPEX-alone categories.
We examined the mitochondrial proteome for likely false positives. We identified 16 proteins that
other studies have demonstrated do not localise to the mitochondrion (Supplementary file 3). Nota-
bly, 14 of these were identified only in the mtBirA* proteome, while one was present in both the
mtBirA* and mtAPEX proteomes, again consistent with the existence of more false positives in the
mtBirA* proteome. In total, of the 421 proteins in the mitochondrial proteome, we identified 97 that
are known or expected to localise to the mitochondrion, and 16 that are known to localise
elsewhere.
Localisation of uncharacterized proteins from the mitochondrial
proteome
Of the 421 putative mitochondrial proteins identified in the mitochondrial proteome, 150 (36%)
were annotated as ‘hypothetical’ proteins, and a further 140 (33%) had no previously defined role or
experimentally determined localization in T. gondii (Supplementary file 1). We attempted to local-
ize 37 proteins selected at random from this ‘uncharacterized’ protein data set by introducing a
hemagglutinin (HA) epitope tag at the 3’ end of the native locus of genes encoding these proteins.
We then undertook immunofluorescence assays to determine the localization of the proteins, co-
labelling with anti-TgTom40 as a marker for the mitochondrion (van Dooren et al., 2016). We were
successful in localizing 27 of the 37 selected proteins. Of these, 22 (81%) localized to the mitochon-
drion, three to the cytosol, one to the endoplasmic reticulum and one to the nucleus (Figure 3). All
13 that were identified in both the mtAPEX and mtBirA* proteomes localized to the mitochondrion,
suggesting a high degree of confidence in the mitochondrial localization of proteins identified from
both datasets. Five of the six proteins found solely in the mtAPEX proteome localized to the mito-
chondrion, while four of the eight proteins found only in the mtBirA* proteome localized to the mito-
chondrion. This is consistent with the dataset of proteins identified only in the mtBirA* proteome
having more false positives than the other datasets.
Phylogenetic analyses of the mitochondrial proteome
We next examined the evolutionary history of proteins from the mitochondrial proteome. First, we
undertook reciprocal Basic Local Alignment Search Tool (BLAST) searches to identify homologs of
proteins from the mitochondrial proteome in the apicomplexan parasites Plasmodium falciparum,
Babesia bovis and Cryptosporidium parvum, and the chromerid Vitrella brassicaformis. Using this
approach, we identified homologs for 71% of T. gondii mitochondrial proteins in P. falciparum, 61%
in B. bovis, 28% in C. parvum, and 83% in V. brassicaformis (Figure 4A).
We were next interested in the extent of novelty in the T. gondii mitochondrial proteome when
compared to non-apicomplexan eukaryotes. We examined conserved orthology groupings of the
421 proteins in the mitochondrial proteome and identified 418 proteins that clustered into 412 sepa-
rate orthology groups (http://orthomcl.org; Chen et al., 2006). We identified 86 proteins that were
unique to T. gondii and closely related coccidians such as Neospora caninum, 243 proteins with
orthologs in non-apicomplexan eukaryotes, and a set of 89 proteins that were found only in apicom-
plexans and/or chromerids (Figure 4B; Supplementary file 1).
Novel drug targets against apicomplexans are likely to emerge from proteins which lack homo-
logs in animals. We therefore conducted an orthology analysis comparing the T. gondii mitochon-
drial proteome to other apicomplexans, chromerids and animals. We found that 51% of the
mitochondrial proteome lacked orthologs in animals, of which 56% had orthologs in other apicom-
plexans and/or chromerids (Figure 4C). The remainder were restricted to T. gondii and other cocci-
dian parasites such as N. caninum.
In an additional analysis, we searched for homologs of proteins from the T. gondii mitochondrial
proteome in a recently-published ‘high-confidence’ mitochondrial proteome of yeast
(Morgenstern et al., 2017). We identified yeast homologs to 161 proteins in the T. gondii mito-
chondrial proteome (Supplementary file 1). Of these, 103 were predicted to localize to the yeast
mitochondrion, and 58 were predicted not to localize to the yeast mitochondrion. The high propor-
tion of non-mitochondrial homologs suggests that aspects of mitochondrial biology in T. gondii may
localize elsewhere in other eukaryotes. Notably, however, 42 of the 58 ‘non-mitochondrial’ proteins
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Figure 3. The localization of novel proteins from the T.gondii mitochondrial proteome. (A–AA) Proteins with no previously determined localization in T.
gondii were selected from the mitochondrial proteome, and the corresponding gene was tagged at the 3’-terminus of the open reading frame with a
HA tag. Immunofluorescence assays depict HA-tagged proteins (green) co-labelled with the mitochondrial marker TgTom40 (red). The http://toxodb.
org gene identification number is depicted for every gene that was tagged.
Figure 3 continued on next page
Seidi et al. eLife 2018;7:e38131. DOI: https://doi.org/10.7554/eLife.38131 8 of 36
Research article Microbiology and Infectious Disease
(72%) were identified in the BirA*-only dataset, which our previous analyses suggest may harbor
more false positives. It is conceivable, therefore, that many of the proteins with non-mitochondrial
homologs in yeast are false positives.
Phenotype analyses of the mitochondrial proteome
Our data indicate substantial novelty in mitochondrial biology of T. gondii and related organisms.
Often, such derived features are less important for an organism’s survival than proteins that have
been conserved across evolution. A recent genome-wide, CRISPR-based loss-of-function screen in T.
gondii found that genes conserved in eukaryotes were, in general, more important for parasite
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.38131.006
The following figure supplement is available for figure 3:
Figure supplement 1. Map of the pgCH plasmid vector, showing the SpeI, BglII and AvrII cut sites between which the 3’ flanks of target genes were
ligated (green), the position of the 1x HA tag (yellow), and the positions of the chloramphenicol resistance marker (ChlR) for T.gondii selection, the
ampicillin resistance marker for E. coli selection (AmpR), and the origin of replication (Ori; all magenta).
DOI: https://doi.org/10.7554/eLife.38131.007
Figure 4. Orthology analyses of proteins from the T.gondii mitochondrial proteome reveal that many mitochondrial proteins are restricted to T. gondii
and related organisms, and that most are important for parasite survival. (A) Bar graph depicting the percentage of orthologs from the mitochondrial
proteome of T. gondii (Tg) found in P. falciparum (Pf), B. bovis (Bb), C. parvum (Cp) and V. brassicaformis (Vb). Phenotype scores are indicated with
shading, and reveal that most ortholog groups in each category are important or critical for tachyzoite growth. (B–C) Venn diagram depicting ortholog
groupings from the mitochondrial proteome of T. gondii compared to (B) non-coccidian apicomplexans, chromerids and eukaryotes, or (C) non-
coccidian apicomplexans, chromerids and animals. (D) Bar graph depicting distribution of phenotype scores in genes belonging to ortholog groups
found only in T. gondii and other coccidians (Tg only), in T. gondii, non-coccidian apicomplexans and chromerids (Tg+ Api+ Chr), and in T. gondii, non-
coccidian apicomplexans, chromerids and animals (Tg+ Api+ Chr+ Api). In (A) and (D), genes with phenotype scores of >-2 were considered
dispensable,  2 to  4 were considered important, and <-4 were considered critical.
DOI: https://doi.org/10.7554/eLife.38131.008
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fitness than genes with a more restricted phylogenetic distribution (Sidik et al., 2016). To determine
whether the same was true for mitochondrial proteins, we analysed the T. gondii mitochondrial pro-
teome using the Sidik et al data set (Sidik et al., 2016). The Sidik et al study ascribed phenotype
scores to each gene in the T. gondii nuclear genome, with more negative scores indicative of a
greater importance for a gene’s contribution to parasite fitness. The Sidik et al study found that
most genes that were important for parasite growth had phenotype scores of below  2, and most
dispensable genes had phenotype scores of greater than  2 (Sidik et al., 2016). Based on this, we
categorised proteins in the mitochondrial proteome as dispensable (phenotype score >-2), impor-
tant ( 2 to  4), or critical (<-4) for parasite growth. Notably, 35% of proteins from the mitochondrial
proteome were critical, and 39% were important, for parasite growth (Figure 4A;
Supplementary file 1). Of the T. gondii mitochondrial proteins with orthologs in P. falciparum,~75%
were important or critical, and similar values apply for those with orthologs in B. bovis, C. parvum,
and V. brassicaformis (Figure 4A). Of the proteins conserved between T. gondii and apicomplexans/
chromerids, over 80% were important or critical for parasite growth, while over 70% of proteins col-
lectively found in apicomplexans, chromerids and animals were important or critical (Figure 4D;
Supplementary file 1).
TgApiCox25 is important for mitochondrial oxygen consumption in T.
gondii.
Having identified ~175 proteins in the T. gondii mitochondrial proteome that have no clear orthologs
outside the apicomplexan/chromerid lineage, and no predicted function, we embarked on a broad
project to characterise the importance and role of these proteins. In the remainder of this manu-
script, we focus on one such protein, annotated as TGGT1_264040, which (for reasons that will
become apparent) we termed TgApiCox25. TgApiCox25 belongs to an OrthoMCL ortholog group-
ing that is restricted to apicomplexans, contains no recognisable functional domains, and is impor-
tant for parasite fitness. It has a predicted molecular mass of 25 kDa, and we confirmed its
localisation to the mitochondrion (Figure 3R). To establish the importance of TgApiCox25 for para-
site growth, and to facilitate subsequent characterisation of its function, we replaced the native pro-
moter of TgApiCox25 with an anhydrotetracycline (ATc)-regulated promoter using a CRISPR-based
genome editing approach (Figure 5—figure supplement 1A). We performed PCR screening analy-
sis to identify clonal parasites that had integrated the ATc-regulated promoter into the TgApiCox25
locus (Figure 5—figure supplement 1B–C). We termed the resultant ATc-regulated TgApiCox25
strain ‘rTgApiCox25’. We then introduced a HA tag at the 3’ end of the open reading frame of the
rTgApiCox25 locus. We termed the resultant HA-tagged, ATc-regulated TgApiCox25 strain ‘rTgApi-
Cox25-HA’. To measure the extent of target protein knockdown upon the addition of ATc in the
rTgApiCox25 strain, we cultured parasites in the absence of ATc, or in the presence of ATc for 1 – 3
days, then undertook western blotting. This revealed substantial depletion of TgApiCox25-HA 2
days after ATc addition, with the TgApiCox25-HA protein barely detectable after 3 days in ATc
(Figure 5A). To determine the importance of TgApiCox25 on parasite growth we compared plaque
sizes of parental wild type (WT) and rTgApiCox25 parasites grown in the absence or presence of
ATc for 9 days. This revealed that growth of rTgApiCox25, but not WT, parasites was severely
impaired in the presence of ATc (Figure 5B–C). Interestingly, rTgApiCox25 parasites grew better in
the absence of ATc than WT parasites (Figure 5B–C). To determine whether the growth phenotype
observed upon TgApiCox25 knockdown was specifically due to loss of TgApiCox25, we comple-
mented the rTgApiCox25 strain with a copy of TgApiCox25 expressed from the constitutive a-tubu-
lin promoter (generating a strain we termed cTgApiCox25-HA/rTgApiCox25). The presence of the
constitutive copy of TgApiCox25 restored growth of rTgApiCox25 parasites in the presence of ATc
(Figure 5B–C).
A major function of the mitochondrion is in oxidative phosphorylation, where the catabolism of
organic molecules by the TCA cycle and other metabolic pathways contributes electrons to an elec-
tron transport chain on the inner membrane of the organelle (van Dooren et al., 2006). Electrons
are ultimately used to reduce O2, with the electron transport chain simultaneously generating a pro-
ton gradient across the inner membrane. This proton gradient is then used to drive the F-type ATP
synthase, a rotary motor that phosphorylates ADP to form ATP, the energy currency of cells. Defects
in any of the processes involved in oxidative phosphorylation will lead to defects in mitochondrial O2
consumption. To test whether TgApiCox25 has a role in oxidative phosphorylation, we established
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Figure 5. TgApiCox25 is important for parasite growth and mitochondrial O2 consumption. (A) Western blot of proteins extracted from rTgApiCox25-
HA parasites grown in the absence of ATc, or in ATc for 1–3 days, and detected using anti-HA antibodies (top) and anti-TgTom40 (as a loading control;
bottom). (B) Plaque assays measuring growth of WT, rTgApiCox25 and complemented cTgApiCox25-HA/rTgApiCox25 parasites cultured in the
absence (top) or presence (bottom) of ATc. Assays are from a single experiment and are representative of 3 independent experiments. (C)
Quantification of plaque size from WT, rTgApiCox25 and complemented cTgApiCox25-HA/rTgApiCox25 parasites grown in the absence or presence of
ATc for 9 days. Box and whisker plots depict the median plaque size (centre line), the 25th and 75th percentiles (box) and the 5th and 95th percentiles
(lines). Data are from 30 plaques per flask from a single experiment, except in the case of the rTgApiCox25 strain, where only 18 plaques were
discernible. (D) Basal mitochondrial oxygen consumption rates (mOCR) in WT parasites grown in the absence of ATc or in the presence of ATc for 3
days (orange), and rTgApiCox25 parasites grown in the absence of ATc, or in the presence of ATc for 1 – 3 days (blue). A linear mixed-effects model
was fitted to the data, and the values depict the mean ± s.e.m. from three independent experiments. A one-way ANOVA followed by Tukey’s multiple
pairwise comparison test was performed. Relevant p values are shown. (E) Basal mOCR plotted against basal extracellular acidification rate (ECAR) of
WT cells grown in the absence of ATc, the presence of cycloheximide (CHX) for 1 day, or the presence of ATc for 3 days, and rTgApiCox25 parasites
grown in the absence of ATc or presence of ATc for 1 – 3 days (mean ± s.e.m. of the linear mixed-effects model described above; n = 3).
DOI: https://doi.org/10.7554/eLife.38131.009
The following figure supplements are available for figure 5:
Figure supplement 1. Generating an ATc-regulated promoter replacement strain of TgApiCox25.
DOI: https://doi.org/10.7554/eLife.38131.010
Figure supplement 2. Knockdown of TgApiCox25 leads to defects in maximal mOCR.
DOI: https://doi.org/10.7554/eLife.38131.011
Figure 5 continued on next page
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an assay to measure O2 consumption by the parasite using a Seahorse XFe96 extracellular flux ana-
lyzer. We grew rTgApiCox25 parasites in the absence of ATc, or presence of ATc for 1 – 3 days then
used the XFe96 analyzer to measure basal mitochondrial O2 consumption rates (mOCR) in extracellu-
lar parasites. This revealed a significant,~80% depletion in basal mOCR upon TgApiCox25 knock-
down (Figure 5D), concomitant with knockdown of protein levels (Figure 5A).
Treatment with the protonophore FCCP uncouples OCR from ATP synthesis and enables the
determination of maximal mOCR in parasites. We found that maximal mOCR was also depleted
upon TgApiCox25 knockdown (Figure 5—figure supplement 2). In a separate study, we demon-
strated that depletion of a component of T. gondii ATP synthase led to an increase in the spare
capacity of mOCR (i.e. the difference between the basal and maximal mOCR; Huet et al., 2018).
We did not observe an increase in spare capacity upon TgApiCox25 knockdown (Figure 5—figure
supplement 2), indicating that TgApiCox25 is not a component of ATP synthase. Basal and maximal
mOCR in WT parasites were unaffected by the addition of ATc, although, curiously, the spare capac-
ity in WT parasites was greater than in rTgApiCox25 parasites grown in the absence of ATc (Fig-
ure 5—figure supplement 2). This is perhaps reflective of changes in TgApiCox25 protein
abundance or timing of expression upon replacing the native promoter with the ATc-regulated
promoter.
We wondered whether the defect in mOCR upon TgApiCox25 knockdown was the result of gen-
eral defects in mitochondrial function or parasite viability. To address this, we first measured the
extracellular acidification rate (ECAR) in WT and rTgApiCox25 parasites grown in the absence or
presence of ATc. ECAR is measured simultaneously with OCR by the XFe96 analyzer. In mammalian
cells, ECAR is thought to depend on the extrusion of lactate, and is therefore a measure of glycolysis
(Ferrick et al., 2008). The contribution of glycolysis and other processes that acidify the extracellular
medium (e.g. activity of the plasma membrane proton pump of these parasites; Moreno et al.,
1998) to ECAR in T. gondii are not yet understood. Nevertheless, we can use ECAR measurements
as a general indication of parasite metabolic activity. ECAR levels in WT and rTgApiCox25 parasites
grown in the absence of ATc was approximately 27 mpH/min/1.5  106 parasites. Growth of TgApi-
Cox25 parasites for 2 or 3 days in ATc resulted in a slight increase in ECAR (Figure 5E), indicating
that parasites remained metabolically active upon TgApiCox25 knockdown. As a control for non-
metabolically active parasites, we treated WT parasites with the translation inhibitor cycloheximide
for 24 hr, which would be expected to deplete key metabolic enzymes in the parasite. XFe96 meas-
urements revealed that both mOCR and ECAR were depleted upon cycloheximide treatment
(Figure 5E), consistent with a general loss of parasite metabolism leading to simultaneous defects in
mOCR and ECAR. We conclude that parasites remain metabolically active in the absence of
TgApiCox25.
Next, we asked whether knockdown of TgApiCox25 led to general defects in mitochondrial mor-
phology. We performed immunofluorescence assays labelling the mitochondrion in rTgApiCox25
parasites grown in the absence or presence of ATc. This revealed no gross morphological defects in
mitochondria upon the loss of TgApiCox25 (Figure 5—figure supplement 3A). Finally, we asked
whether T. gondii parasites remained viable upon knockdown of TgApiCox25. We pre-incubated
rTgApiCox25 parasites in the presence of ATc for 3 days. We then set up plaque assays in the
absence or presence of ATc, comparing parasite growth with parasites that had not been pre-incu-
bated in ATc. As expected, parasites that were maintained in ATc for the duration of the plaque
assay underwent minimal growth, regardless of whether they were pre-incubated in ATc (Figure 5—
figure supplement 3B). Notably, plaque number and size were equivalent between pre-incubated
Figure 5 continued
Figure supplement 3. Defects in mOCR upon TgApiCox25 knockdown are not the result of general defects in mitochondrial morphology or parasite
viability.
DOI: https://doi.org/10.7554/eLife.38131.012
Figure supplement 4. Map of the pUgCTH3 plasmid vector, showing the BglII and AvrII cut sites between which the TgApiCox25 open reading frame
was ligated (green), the position of the 3x HA tag (yellow) and a-tubulin 5’ region (blue), and the positions of the chloramphenicol resistance marker
(ChlR) for T.gondii selection, the UPRT flank (linearized at the indicated MfeI site before transfection), the ampicillin resistance marker for E. coli
selection (AmpR), and the origin of replication (Ori; all magenta).
DOI: https://doi.org/10.7554/eLife.38131.013
Seidi et al. eLife 2018;7:e38131. DOI: https://doi.org/10.7554/eLife.38131 12 of 36
Research article Microbiology and Infectious Disease
and non-pre-incubated parasites when grown in the absence of ATc. This reveals that TgApiCox25
knockdown is reversible and, importantly, that rTgApiCox25 parasites treated for 3 days on ATc
have equivalent viability to rTgApiCox25 not grown on ATc.
The data presented here indicate that the defects we observed in mitochondrial O2 consumption
upon TgApiCox25 knockdown were not due to general defects in parasite viability, metabolism or
mitochondrial morphology. We conclude that TgApiCox25 has an important, specific role in oxida-
tive phosphorylation in T. gondii parasites.
TgApiCox25 is a component of cytochrome c oxidase
Our findings that TgApiCox25 is critical for mitochondrial O2 consumption prompted us to investi-
gate whether this protein is a component of the mitochondrial electron transport chain that medi-
ates O2 consumption. The mitochondrial electron transport chain consists of several large protein
complexes. To determine whether TgApiCox25 exists in a protein complex, we extracted proteins
from TgApiCox25-HA parasites using 1% (v/v) Triton X-100 detergent, and separated these proteins
by blue native-PAGE, a technique that preserves the native conformation of proteins and protein
complexes. Western blotting of TgApiCox25-HA extracts separated by blue native-PAGE and
detected with anti-HA antibodies revealed that TgApiCox25-HA exists at a molecular mass of ~600
kDa (Figure 6A). By contrast, the monomeric form of TgApiCox25-HA, extracted from parasites and
separated by SDS-PAGE, had a mass of approximately 25 kDa (Figure 6B). We conclude that TgApi-
Cox25 is a component of a ~ 600 kDa protein complex in the parasite mitochondrion.
To elucidate the proteins that comprise the TgApiCox25-containing complex, we immunoprecipi-
tated TgApiCox25-HA and associated proteins with anti-HA-coupled agarose beads (Figure 6—fig-
ure supplement 1A), then performed mass spectrometry to identify the proteins that were part of
this complex. As a negative control, we immunopurified TgTom40-HA (Figure 6—figure supple-
ment 1B), the central protein of the ~400 kDa translocon of the outer mitochondrial membrane
(TOM) complex (van Dooren et al., 2016), and subjected these extracts to mass spectrometry-
based protein identification. Using this approach, we identify 12 proteins, including TgApiCox25,
that were enriched in the TgApiCox25-HA immunoprecipitation compared to the TgTom40-HA
immunoprecipitation (Figure 6C; Table 1; Supplementary file 5). Of these 12 proteins, three are
annotated as being canonical components of cytochrome c oxidase (COX, also known as Complex
IV of the mitochondrial electron transport chain; Figure 6C; Table 1). These proteins included
TgCox2A (TGGT_226590) and TgCox2b (TGGT1_310470), split Cox2 homologs that are found in
apicomplexans and which have previously been localised to the mitochondrion of T. gondii
(Funes et al., 2002; Morales-Sainz et al., 2008), as well as TgCox5b (TGGT1_209260). Profile hid-
den Markov model similarity searches revealed that 7 of the remaining 8 TgApiCox25-associated
proteins have homologs in other apicomplexans as well as in chromerids, whereas one
(TGGT1_265370; TgApiCox16) is restricted to T. gondii (Table 1). All of the proteins detected were
identified in the mitochondrial proteome (Table 1; Supplementary file 1), including TGGT1_297810
(TgApiCox30), an HA-tagged version of which we previously confirmed localizes to the mitochon-
drion in immunofluorescence assays (Figure 3X). All these proteins except TgApiCox16 are pre-
dicted to be important for growth of the tachyzoite stage of T. gondii (Table 1; Sidik et al., 2016).
Three further proteins, TGGT1_254030, TGGT1_242840, and a cytochrome c oxidase subunit III
(CoxIII) homologue (TGVEG_442760), were highly enriched in the TgApiCox25 immunoprecipitation
but excluded from our analysis because they were absent from at least one replicate of the control
data set (Supplementary file 5; Table 1). Both TGGT1_254030 and TGGT1_242840 were present in
the mitochondrial proteome, and were predicted to be important for parasite growth.
TGGT1_242840 was phylogenetically restricted to apicomplexans and chromerids, whereas
TGGT1_254030 had homology to the human CDGSH iron-sulfur domain containing protein 3
(Table 1).
As a direct test for whether TgApiCox25 interacts with TgCox2a, we introduced a FLAG epitope
tag into the native locus of TgCox2a in the TgApiCox25-HA background strain, generating a strain
we termed TgCox2a-FLAG/TgApiCox25-HA (Figure 7—figure supplement 1A–B). We separated
proteins from the TgCox2a-FLAG/TgApiCox25-HA strain using blue native-PAGE and performed
western blotting with anti-FLAG antibodies. This revealed that TgCox2a-FLAG exists in a protein
complex of ~600 kDa (Figure 7A). Immunoprecipitation of TgCox25-HA with anti-HA antibodies co-
purified TgCox2a-FLAG, but not TgAtpB, the b–subunit of the F1 domain of ATP synthase, or the
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mitochondrial outer membrane protein TgTom40 (Figure 7B). Similarly, immunoprecipitation of
TgCox2a-FLAG with anti-FLAG antibodies co-purified TgApiCox25, but not TgAtpB or TgTom40
(Figure 7B). Together, these data indicate that TgCox2a-FLAG exists in the same complex as TgApi-
Cox25-HA.
To test whether TgApiCox25 interacts with TgApiCox30, we introduced a FLAG epitope tag into
the native locus of TgApiCox25 in the TgApiCox30-HA background, generating a strain we termed
TgApiCox25-FLAG/TgApiCox30-HA (Figure 7—figure supplement 1C–D). Western blots of pro-
teins separated by blue native-PAGE indicated that both TgApiCox25-FLAG and TgApiCox30-HA
exist in a ~600 kDa protein complex (Figure 7C). Immunoprecipitation of TgApiCox30 with anti-HA
antibodies purified TgApiCox25 but not TgAtpB or TgTom40, and immunoprecipitation of TgApi-
Cox25 with anti-FLAG antibodies co-purified TgApiCox30 but not TgAtpB or TgTom40 (Figure 7D).
We conclude that TgApiCox25-FLAG and TgApiCox30-HA exist in the same protein complex.
Combined with the observation that TgApiCox25 is important for mitochondrial O2 consumption
(Figure 5D), these data are consistent with the hypothesis that TgApiCox25 and TgApiCox30 are
components of the parasite COX complex, the terminal oxidase of the mitochondrial electron trans-
port chain that facilitates the reduction of O2. To reflect their apparent phylogenetic restriction to
apicomplexans and related organisms, we have termed the apicomplexan-specific components of
the T. gondii COX complex as ‘ApiCox’ proteins, with the numerical suffix indicating the predicted
molecular mass of the protein (Table 1).
Figure 6. TgApiCox25 is part of a 600 kDa protein complex and co-purifies with canonical components of the cytochrome c oxidase complex. (A)
Western blot of proteins extracted from TgApiCox25-HA parasites, separated by blue native-PAGE, and detected with anti-HA antibodies. (B) Western
blot of proteins extracted from TgApiCox25-HA parasites, separated by SDS-PAGE, and detected with anti-HA antibodies. (C) Volcano plot showing
the log2 fold change vs –log10 p values of proteins purified from TgApiCox25-HA vs TgTom40-HA parasites using anti-HA immunoprecipitations and
detected by mass spectrometry. Only proteins detected in each of the three independent experiments for both parasite lines are depicted. Proteins
enriched in the TgApiCox25-HA samples (p<0.05; log2 fold change >5) have been coded according to whether they are orthologous to canonical
cytochrome c oxidase subunits (green triangles), or restricted to the apicomplexan lineage (blue circles; ApiCox subunits). TgApiCox25 is also depicted
(red diamond).
DOI: https://doi.org/10.7554/eLife.38131.014
The following figure supplement is available for figure 6:
Figure supplement 1. Immunopurification of the TgApiCox25 and TgTom40 protein complexes.
DOI: https://doi.org/10.7554/eLife.38131.015
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Table 1. Summary of the features of proteins identified in proteomic analysis of the TgApiCox25 complex.
Similarity searches were performed using HMMER (https://www.ebi.ac.uk/Tools/hmmer/). The accession numbers listed were derived
from http://EuPathDB.org (apicomplexan and chromerid species) or www.ncbi.nlm.nih.gov (all others). Abbreviations: Plasmodium fal-
ciparum (Pf), Cryptosporidium parvum (Cp), Vitrella brassicaformis (Vb), Saccharomyces cerevisiae (Sc), Homo sapiens (Hs), Arabidopsis
thaliana (At).
ToxoDB gene
ID (http://
toxodb.org)
Protein
annotation
Predicted
protein
mass
(kDa)
Mitochon-
drial
proteome
(this
study)
Phenotype
score
(Sidik et al.,
2016)
Similarity search
(E-value)
Pf Cp
Vb
(Chromerid)
Sc
(Fungi)
Hs
(Animal)
At
(Plant)
TGGT1_264040 Hypothetical
protein
(TgApiCox25)
24.5 [  2.54 Conserved
unknown protein
PF3D7_1464000.1
(2.4e 53)
x Hypothetical
Protein
Vbra_12326 .t1
(5.2e 29)
x x x
TGGT1_265370 Hypothetical
protein
(TgApiCox16)
16.0 [ 1.56 x x x x x x
TGGT1_209260 Putative
cytochrome c
oxidase subunit
(TgCox5b)
34.8 [  3.07 Putative COX5B
PF3D7_0927800.1
(4.3e 101)
x COX5B-2
Vbra_9355 .t1
(1.6e 92)
Cox4p
P04037
(0.32)
Cox5B
NP_001853.2
(0.05)
COX5b
At1g80230
(2.1e 08)
TGGT1_221510 Hypothetical
protein
(TgApiCox18)
17.9 [  3.28 Conserved
unknown protein
PF3D7_0523300.1
(1.5e 48)
x Hypothetical
Protein
Vbra_21271 .t1
(5.2e 45)
x x x
TGGT1_262640 Cg8 family
protein
(TgApiCox23)
23.8 [  3.49 Cg8 protein
PF3D7_0708700.1
(3.1e 64)
x Hypothetical
Protein
Vbra_3012 .t1
(2.4e 53)
x x x
TGGT1_297810 Hypothetical
protein
(TgApiCox30)
29.6 [  3.64 Conserved
unknown protein
PF3D7_0915700.1
(1.2e 46)
x Hypothetical
Protein
Vbra_17445 .t1
(6.7e 33)
x x x
TGGT1_247770 Hypothetical
protein
(TgApiCox19)
19.2 [  2.61 Conserved
unknown protein
PF3D7_1402200.1
(1.2e 34)
x Hypothetical
Protein
Vbra_2065 .t1
(1.7e 27)
x x x
TGGT1_229920 Hypothetical
protein
(TgApiCox35)
35.0 [  3.84 Conserved
unknown protein
PF3D7_0306500.1
(1.5e 90)
x Hypothetical
Protein
Vbra_6819 .t1
(1.6e 73)
x x x
TGGT1_306670 Hypothetical
protein
(TgApiCox26)
25.8 [  3.68 Conserved
unknown protein
PF3D7_1439600.1
(2.6e 43)
x Hypothetical
Protein
Vbra_888 .t1
(1.2e 36)
x x x
TGGT1_226590 Putative
cytochrome c
oxidase subunit
(TgCox2a)
34.5 [  3.80 Cytochrome c
oxidase subunit 2
PF3D7_1361700.1
(4.9e 58)
x Cytochrome c
oxidase
subunit 2
Vbra_8641 .t1
(3.6e 33)
Cox2
P00410
(2.6e 06)
Cox2
P00403
(0.0004)
Cox2
P93285
(3.3e 06)
TGGT1_310470 Putative
cytochrome c
oxidase subunit
(TgCox2b)
21.2 [  4.18 Cytochrome c
oxidase subunit 2
PF3D7_1430900.1
(7.6e 75)
x Cytochrome c
oxidase
subunit 2
Vbra_14923 .t1
(4.2e 7)
Cox2
P00410
(4.3e 31)
Cox2
P00403
(9.2e 29)
Cox2
P93285
(3.8e 37)
TGGT1_286530 Hypothetical
protein
(TgApiCox24)
25.4 [  2.82 Conserved
unknown protein
PF3D7_1362000.1
(6.0e 45)
x Hypothetical
Protein
Vbra_10089 .t1
(1.2e 11)
x x x
Table 1 continued on next page
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To investigate whether proteins from the TgApiCox25 complex might have structural similarity to
known proteins, we queried each protein enriched in the TgApiCox25 immunoprecipitation against
the Protein Data Bank (PDB) using HHPRED, a profile hidden Markov model search tool that also
incorporates secondary structure information (Zimmermann et al., 2018). As expected, TgCox2a,
TgCox2b, TgCoxIII, and TgCox5b had homology to equivalent cytochrome c oxidase proteins from
other eukaryotes (probability >98.9%, e value <6.6 e 11 for each). Interestingly, TgApiCox25 had
predicted homology to cytochrome c oxidase complex subunit 6A from Bos taurus (PDB annotation
5B1A_T; probability 90.9%, e value 0.58) and TgApiCox23 had predicted homology to cytochrome c
oxidase complex subunit four from Bos taurus (PDB annotation 5B1A_D; probability 95.57%, e value
0.0057). Of the remaining ApiCox proteins, ApiCox13 was predicted to have homology to the mito-
chondrial matrix-localized CDGSH iron-sulfur domain containing protein 3 of humans (PDB annota-
tion 6AVJ_C; probability 99.95, e value 3.1 e 31), an iron-sulfur cluster-containing NEET-family
protein important for mitochondrial iron homeostasis (Lipper et al., 2018). None of the remaining
ApiCox proteins were matched to proteins from PDB with any great confidence (probability of
homology to the top ‘hit’<70%, e value >5 for all).
To obtain insights into the role of TgApiCox25 in the parasite COX complex, we tested the
effects of TgApiCox25 knockdown on complex integrity. We introduced a FLAG epitope tag into
the TgCox2a locus of the rTgApiCox25-HA parasite strain, generating a strain we term TgCox2a-
FLAG/rTgApiCox25-HA (Figure 7—figure supplement 1A–B). We grew parasites in the absence of
ATc or the presence of ATc for 1 – 3 days, then separated protein extracts by SDS-PAGE. As demon-
strated previously, ATc treatment led to depletion of TgApiCox25 but not of a TgTom40 loading
control (Figure 7E). Interestingly, knockdown of TgApiCox25 also led to depletion of TgCox2a-
FLAG, although not to the same extent as TgApiCox25 (Figure 7E). We solubilised proteins from
the TgApiCox25-HA/TgCox2a-FLAG strain in 1% (v/v) Triton X-100 and separated proteins by blue
native PAGE. Knockdown of TgApiCox25 led to depletion of the ~600 kDa COX complex
(Figure 7F). Interestingly, TgApiCox25 knockdown resulted in the appearance of a ~ 400 kDa com-
plex that contains TgCox2a (Figure 7D). Together, these observations are consistent with TgApi-
Cox25 having an important role COX complex integrity, stability and/or assembly.
Discussion
In this study, we utilised two spatially-restricted biotin tagging approaches to elucidate the prote-
ome of the mitochondrial matrix of T. gondii. These complementary approaches identified approxi-
mately 400 putative mitochondrial proteins. This number is slightly lower than the 495 proteins
identified in the mtAPEX-derived proteome of mammalian cells (Rhee et al., 2013), and is less than
Table 1 continued
ToxoDB gene
ID (http://
toxodb.org)
Protein
annotation
Predicted
protein
mass
(kDa)
Mitochon-
drial
proteome
(this
study)
Phenotype
score
(Sidik et al.,
2016)
Similarity search
(E-value)
Pf Cp
Vb
(Chromerid)
Sc
(Fungi)
Hs
(Animal)
At
(Plant)
TGGT1_254030 Zinc finger
CDGSH-type
domain-
containing
protein
(TgApiCox13)
13.2 [  4.26 CDGSH iron-
sulfur domain-
containing
protein
PF3D7_1022900.1
(7.8e 42)
x CDGSH iron-
sulfur domain-
containing
protein 3
Vbra_4701 .t1
(1.2e 44)
x CDGSH iron-
sulfur domain-
containing
protein 3
(2.7e 11)
x
TGGT1_242840 Membrane
protein
(TgApiCox14)
13.9 [  3.58 Conserved
unknown protein
PF3D7_1339400.1
(4.1e 16)
x Hypothetical
Protein
Vbra_9996 .t1
(1.8e 9)
x x x
TGVEG_442760 Cytochrome C
family oxidase
subunit III
(TgCoxIII)
16.8 - N/A Cytochrome c
oxidase subunit 3
mal_mito_1
(5.2e 5)
x x x x x
DOI: https://doi.org/10.7554/eLife.38131.016
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Figure 7. TgApiCox25 is a component of T.gondii cytochrome c oxidase and important for complex integrity. (A) Anti-FLAG western blot of proteins
from the TgCox2a-FLAG/TgApiCox25-HA strain separated by blue native-PAGE. (B) Western blots of proteins extracted from the TgCox2a-FLAG/
TgApiCox25 HA strain and subjected to immunoprecipitation using anti-HA (anti-HA IP) or anti-FLAG (anti-FLAG IP) antibody-coupled beads. Extracts
include samples before immunoprecipitation (Total), samples that did not bind to the anti-HA or anti-FLAG beads (Unbound), and samples that bound
to the anti-HA or anti-FLAG beads (Bound). Samples were probed with anti-HA to detect TgApiCox25-HA, anti-FLAG to detect TgCox2a-FLAG, anti-
AtpB to detect the b-subunit of T. gondii ATP synthase, and anti-TgTom40. (C) Anti-HA (left) and anti-FLAG (right) western blots of proteins from the
TgApiCox25-FLAG/TgApiCox30-HA strain separated by blue native-PAGE. (D) Western blots of proteins extracted from the TgApiCox25-FLAG/
TgApiCox30-HA strain and subjected to immunoprecipitation using anti-HA (anti-HA IP) or anti-FLAG (anti-FLAG IP) antibody-coupled beads. Extracts
include samples before immunoprecipitation (Total), samples that did not bind to the anti-HA or anti-FLAG beads (Unbound), and samples that bound
to the anti-HA or anti-FLAG beads (Bound). Samples were probed with anti-HA to detect TgApiCox30-HA, anti-FLAG to detect TgApiCox25-FLAG,
anti-AtpB, and anti-TgTom40. (E) Western blot of proteins extracted from rTgApiCox25-HA/TgCox2a-FLAG parasites grown in the absence of ATc, or
in ATc for 1 – 3 days, separated by SDS-PAGE and detected using anti-HA (top), anti-FLAG (middle) and anti-TgTom40 (as a loading control; bottom).
(F) Western blot of proteins extracted from TgCox2a-FLAG/rTgApiCox25-HA parasites grown in the absence of ATc, or in ATc for 1 – 3 days, separated
by blue native-PAGE, and detected using anti-FLAG antibodies.
DOI: https://doi.org/10.7554/eLife.38131.017
The following figure supplement is available for figure 7:
Figure supplement 1. Generating FLAG tagged TgCox2a and TgApiCox25 strains.
DOI: https://doi.org/10.7554/eLife.38131.018
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the 750 – 900 proteins identified in yeast studies using highly purified mitochondria
(Morgenstern et al., 2017; Sickmann et al., 2003). Our proteome identified most of the proteins
‘expected’ to localize to the T. gondii mitochondrion (Figure 2D; Supplementary file 3), suggesting
a high level of coverage. The lowered numbers of proteins in the T. gondii mitochondrial proteome
compared to the yeast mitochondrial proteome may represent reduced functions in the parasite
organelle compared to that in a metabolically flexible organism such as yeast, although our subse-
quent analyses (discussed below) are consistent with the presence of a high degree of divergent
biology in apicomplexan mitochondria.
We experimentally localized 27 previously uncharacterised proteins from the T. gondii mitochon-
drial proteome, finding that 22 of these localised to the mitochondrion (Figure 3). From this, we esti-
mate that ~80% of the ‘uncharacterized’ proteins from the proteome localize to the mitochondrion.
Our findings suggest a low false positive rate in the proteins identified from the APEX proteome
alone (~5%), but a higher false positive rate in the mtBirA* proteome (~20%). Based on these analy-
ses, we consider the 213 proteins from the mtAPEX and shared mtAPEX/mtBirA* proteomes to be
‘likely’ mitochondrial proteins, and the 208 proteins found in the mtBirA* proteome alone to be
‘possible’ mitochondrial proteins.
To our knowledge, our study is the first time the APEX and BirA* restricted biotinylation
approaches have been directly compared in organellar proteomic approaches. Bioinformatic and
localization analyses indicate a high level of overlap between the two approaches, but also indicate
the presence of unique proteins in both data sets. This suggests that the two approaches provide
complementary information that expands the organellar proteome, while at the same time providing
confidence in the shared set of proteins that were identified. The mtBirA*-derived proteome identi-
fied greater numbers of proteins, while also featuring greater numbers of false positives.
The mtAPEX labelling was performed over a short timeframe in extracellular parasites, whereas
the mtBirA* labelling was performed across 24 hr in intracellular parasites. The differences we see in
these proteomes may, in part, result from differences in the labelling conditions. In this regard, it is
notable that of the 20 ‘expected’ mitochondrial ribosomal protein and ribosome assembly factors,
17 were only present in the (intracellular) mtBirA* proteome (Supplementary file 3). Future work
could examine whether there are differences in mitochondrial ribosome assembly and abundance
between intra- and extra-cellular parasites. Similarly, mitochondrial carrier proteins, which mediate
the transport of solutes into and out of the mitochondria, were enriched in the APEX proteome (5 of
the six carrier proteins identified were present in the ‘APEX only’ proteome, and the other in both
proteomes; Supplementary file 1). This may reflect either differences in the abundance of these
proteins in intra- vs extra-cellular parasites, or in different labelling affinities for these integral mem-
brane proteins between biotin-phenol and BirA*-catalysed biotinylation.
Several recent studies have used BirA* to identify novel proteins in apicomplexan organelles
(Boucher et al., 2018; Chen et al., 2015; Kehrer et al., 2016; Nadipuram et al., 2016). Our study
is the first time APEX has been used for proteomic applications in apicomplexan parasites, and we
suggest that this approach will prove useful in elucidating the proteomes of other apicomplexan
organelles (e.g. the apicoplast) or organellar sub-compartments (e.g. the mitochondrial intermem-
brane space), either by itself or in combination with BirA* approaches. Our study suggests that
APEX and BirA* are powerful tools in determining organellar proteomes in apicomplexans.
Our phylogenetic comparisons suggest that a large number of proteins in the T. gondii mitochon-
drion have homologs in P. falciparum (Figure 4A; Supplementary file 1). This is consistent with the
presence of similar mitochondrial processes and biochemical pathways in these organisms
(Seeber et al., 2008). The lower value in C. parvum is consistent with the reduced function of the
mitosome of this organism (Mogi and Kita, 2010). The shared mitochondrial/mitosomal proteome
of T. gondii and C. parvum likely consists of proteins involved in pathways shared between these
organisms, such as Fe-S cluster synthesis. Notably, we identified homologs to 83% of T. gondii mito-
chondrial proteins in the chromerid V. brassicaformis (Figure 4A; Supplementary file 1). This mirrors
recent findings that several ‘derived’ features of apicomplexan mitochondria, including the repurpos-
ing of the BCKDH, the loss of Complex I, and the acquisition of novel TCA cycle enzymes, were
already present in the free-living, autotrophic common ancestor of myzozoans (dinoflagellates, chro-
merids and apicomplexans; Danne et al., 2013; Jacot et al., 2016). Notably, most of the ApiCox
proteins we identified in the T. gondii COX complex had homologs in chromerids (Table 1), indicat-
ing that even conserved mitochondrial processes in this group of organisms have a considerable
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degree of novelty. Our findings mirror those of two recent studies that examined the mitochondrial
ATP synthase complex of T. gondii, which also contains many subunits that are conserved between
apicomplexans and their nearest free-living relatives (Huet et al., 2018; Salunke et al., 2018).
Together, these data indicate that much of the mitochondrial biology in T. gondii was present in the
free-living ancestor that they share with chromerids.
Many (~40 – 50%) mitochondrial proteins in T. gondii lack apparent orthologs in animals and
other eukaryotes (Figure 4B–C). Surprisingly, proteins found only in coccidians, or restricted to api-
complexans and chromerids, were just as likely to be important for parasite growth as proteins con-
served across eukaryotic evolution (Figure 4D). This suggests that many derived or unique features
of the T. gondii mitochondrion (and apicomplexan mitochondria more generally) are critical for para-
site survival. This is in contrast to the general proteome of T. gondii, where proteins with a restricted
phylogenetic distribution are typically less important for parasite survival (Sidik et al., 2016).
To understand the functions of apicomplexan-specific mitochondrial proteins that are important
for parasite growth, we have commenced a project to characterize these proteins. In this study, we
describe the characterisation of TgApiCox25, demonstrating that this is a component of the T. gon-
dii COX complex. TgApiCox25 is important for parasite growth and mitochondrial oxygen consump-
tion (Figure 5). Knockdown of TgApiCox25 also leads to defects in the integrity of the COX
complex. In particular, TgApiCox25 knockdown leads to a depletion of TgCox2a abundance, and
also results in the appearance of a smaller,~400 kDa TgCox2a-containing complex (Figure 7E–F).
These data imply an important role for TgApiCox25 in the assembly and/or stability of the COX
complex. It remains unclear whether loss of TgApiCox25 leads to loss of a ~ 200 kDa module from
the complex, or whether TgApiCox25 knockdown leads to defects in COX assembly, with the ~400
kDa complex representing an assembly intermediate. Regardless, loss of TgApiCox25 results in
defects in the abundance and integrity of the parasite COX complex, which likely explains the
defects in mOCR observed upon TgApiCox25 knockdown. Future studies will examine the functional
role of TgApiCox25 in the COX complex of the parasite.
Our analysis of the parasite COX complex revealed that it is approximately 600 kDa in mass
(Figure 6A), which is larger than the equivalent complex in yeast (200 kDa), mammals (200 kDa) and
plants (220/300 kDa) (Eubel et al., 2003; Lenaz and Genova, 2010; Mare´chal et al., 2012;
Scha¨gger and Pfeiffer, 2000; Tsukihara et al., 1996). It is conceivable that the T. gondii COX com-
plex exists in a multimeric form (e.g. a homodimer or homotrimer), and/or that it contains subunits
not present in the complex of these other organisms that inflate its mass. Another possibility is that
T. gondii COX exists in a ‘super-complex’ with other respiratory complexes, as has been observed in
other systems (Eubel et al., 2003; Scha¨gger and Pfeiffer, 2000). Although we cannot rule out that
respiratory chain supercomplexes exist in T. gondii, the 600 kDa complex is probably not a super-
complex, since (i) we do not observe enrichment of canonical components of other respiratory chain
proteins in our proteomic analysis of the complex, (ii) we solubilised the cytochrome c oxidase com-
plex with Triton X-100 detergent, rather than digitonin (which is typically used to solubilize super-
complexes in other organisms; Scha¨gger and Pfeiffer, 2000), and (iii) the molecular masses of other
respiratory chain complexes in T. gondii do not correspond in size to COX (GvD, unpublished
observations).
We identified 15 proteins in the T. gondii COX complex. In addition to these, it is likely that the
complex contains TgCoxI, a protein encoded on the mitochondrial genome of the parasite. 16 COX
proteins in T. gondii is comparable in number to those found in the mammalian (13 proteins) and
plant (10 or 12 proteins) complexes (Eubel et al., 2003; Tsukihara et al., 1996). Surprisingly, only a
few T. gondii COX proteins have obvious homologs in eukaryotes outside the myzozoan lineage. Of
note, 10 of the 11 ApiCox proteins we identified have homologs in chromerids (Table 1), while only
TgApiCox13 has a clear homolog in ciliates (http://orthomcl.org), the eukaryotic lineage that is the
sister taxon to myzozoans. This suggests either a high degree of novelty in the proteins that com-
prise the T. gondii/myzozoan COX complex, or that the sequences of ApiCox proteins have
diverged to the extent that they are no longer easily recognisable by sequence comparisons. Nota-
bly, similarity searches that incorporate secondary structure information suggest that ApiCox25 and
ApiCox23 may have homology to Cox6a and Cox4, respectively, from animals. A priority in the field
is to establish the structure of the COX complex in myzozoans, which will reveal whether ApiCox
proteins have structural equivalents in other eukaryotes. Regardless of their degree of novelty, our
observations are consistent with other observations that suggest a considerable divergence in the
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mitochondrial biology of organisms from the myzozoan lineage compared to other eukaryotes
(Danne et al., 2013; Huet et al., 2018; Jacot et al., 2016; Salunke et al., 2018).
Our study highlights the divergence of mitochondrial proteomes across the eukaryotic domain of
life. Future studies will be aimed at elucidating the function of other T. gondii- and myzozoan-spe-
cific mitochondrial proteins, since these proteins will provide insights into unique functions of the
organelle. Given their importance to parasite growth, and their absence (or divergence) from the
host organisms that they infect, these T. gondii and apicomplexan-specific proteins are prime drug
targets.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Toxoplasma gondii)
RHDhxgprt PMID: 8662859 Parental strain for
mtAPEX and
mtBirA* strains
Strain, strain
background (T. gondii)
mtAPEX-cmyc
in RHDhxgprt
This paper mtAPEX-cmyc-
expressing
T. gondii
Strain, strain
background (T. gondii)
mtBirA*-cmyc in RHDhxgprt This paper mtBirA*-cmyc-
expressing
T. gondii
Strain, strain
background (T. gondii)
TATi/Dku80 PMID: 22144892 Parental for 3’ HA tag
integration strains and
rTgApiCox25 strain and
derivatives thereof
Strain, strain
background (T. gondii)
TGGT1_209420 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_209870 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_210730 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_213420 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_217020 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_220100 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_223500 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_229620 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_232600 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_248600 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background (T. gondii)
TGGT1_258100 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_259710 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_260840 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_263080 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_263400 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_263840 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_265360 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_264040 HA
in TATi/Dku80
This paper Gene contains
integrated
3’ HA tag; termed
TgApiCox25-HA strain
Strain, strain
background (T. gondii)
TGGT1_275650 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_278250 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_278720 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_286120 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_290460 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_297810 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag;
termed
TgApiCox30-HA strain
Strain, strain
background (T. gondii)
TGGT1_300030 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_316900 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
TGGT1_318400 HA
in TATi/Dku80
This paper Gene contains
integrated 3’ HA tag
Strain, strain
background (T. gondii)
rTgApiCox25
in TATi/Dku80
This paper ATc-regulated
promoter driving
TgApiCox25 expression
Strain, strain
background (T. gondii)
rTgApiCox25-HA This paper Regulatable TgApiCox25
gene with integrated
3’ HA tag
Strain, strain
background (T. gondii)
cTgApiCox25-HA/
rTgApiCox25
This paper rTgApiCox25 strain
complemented with
constitutive TgApiCox25-HA
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background (T. gondii)
TgCox2A-FLAG in
TgApiCox25-HA
This paper Integrated 3’ FLAG
tag in TgCox2a locus of
TgApiCox25-HA strain
Strain, strain
background (T. gondii)
TgCox2A-FLAG
in rTgApiCox25-HA
This paper Integrated 3’ FLAG
tag in TgCox2a locus of
rTgApiCox25-HA strain
Strain, strain
background (T. gondii)
TgApiCox25-FLAG
in TgApiCox30-HA
This paper Integrated 3’ FLAG
tag in TgApiCox25 locus of
TgApiCox30-HA strain
Cell line
(Homo sapians)
Human Foreskin
Fibroblasts
Gift from
Holger Schu¨lter,
Peter MacCallum
Cancer Centre
Antibody mouse anti-cmyc Santa Cruz Clone 9E10 (1:200 to 1:500)
Antibody rat anti-HA Sigma Clone 3F10 (1:200 to 1:1,000)
Antibody mouse anti-FLAG Sigma Clone M2 (1:500 to 1:2,000)
Antibody rabbit anti-AtpB Agrisera cat #: AS05 085 (1:500)
Antibody rabbit anti-TgTom40 PMID: 27458014 (1:2,000)
Antibody rabbit anti-TgCytC This paper Peptide antibody made
against residues 1–14
(MSRAEPDVQVPSGD) of
T. gondii cytochrome c
(TGGT1_219750) (1:500)
Antibody rabbit anti-Hsp60 PMID: 15279947 (1:1,000)
Antibody goat anti-mouse
Alexa Fluor 488
Life
Technologies
cat #: A11029 (1:500)
Antibody goat anti-rat Alexa
Fluor 488
Life
Technologies
cat #: A11006 (1:100 to 1:500)
Antibody goat anti-rat CF
488A
Sigma cat #:
SAB4600046
(1:100 to 1:500)
Antibody goat anti-rabbit
Alexa Fluor 546
Life
Technologies
cat #: A11035 (1:500)
Antibody goat anti-mouse
HRP-conjugated
Santa Cruz cat #: sc-2005 (1:5,000)
Antibody goat anti-rat
HRP-conjugated
Santa Cruz cat #: sc-2006 (1:5,000)
Antibody goat anti-rabbit
HRP-conjugated
Santa Cruz cat #: sc-2004 (1:5,000)
Antibody anti-mouse
HRP-conjugated
TrueBlot Ultra
eBioscience cat #:
18-8817-31
(1:5,000)
Antibody anti-FLAG M2
affinity gel
Sigma cat #: A2220
Antibody anti-HA affinity
matrix
Sigma cat #:
11815016001
Peptide,
recombinant protein
Avidin,
Oregon Green
-conjugated
Life
Technologies
cat #: A6374 (1:1,000)
Peptide,
recombinant protein
NeutrAvidin,
HRP-conjugated
Life
Technologies
cat #: A2664 (1:10,000)
Peptide,
recombinant protein
Streptavidin
magnetic beads
Thermo
Scientific
cat #: PIE88817
Recombinant
DNA reagent
pcDNA3-mito-APEX PMID: 23086203 Addgene cat
# 42607
Continued on next page
Seidi et al. eLife 2018;7:e38131. DOI: https://doi.org/10.7554/eLife.38131 22 of 36
Research article Microbiology and Infectious Disease
Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Recombinant
DNA reagent
pBirA* 3XhA-
LIC-DHFR
PMID: 25691595
Recombinant
DNA reagent
pSAG1::Cas9-
U6::sgUPRT
PMID: 24825012 Addgene cat
# 54467
Recombinant
DNA reagent
pUgCTH3 PMID: 28205520
Recombinant
DNA reagent
mtAPEX-cmyc in
pBTM3
This paper T. gondii expression
vector encoding
mitochondrially
targeted APEX
Recombinant
DNA reagent
mtBirA*-cmyc in
pBTM3
This paper T. gondii expression vector
encoding mitochondrially
targeted APEX
Recombinant
DNA reagent
TGGT1_209420 HA
in pgCH
This paper T. gondii 3’ replacment vector
that introduces 1xHA tag
into target gene
Recombinant
DNA reagent
TGGT1_209870 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces 1xHA
tag into target gene
Recombinant
DNA reagent
TGGT1_210730 HA
in pgCH
This paper T. gondii 3’ replacment vector
that introduces 1xHA tag into
target gene
Recombinant
DNA reagent
TGGT1_213420 HA
in pgCH
This paper T. gondii 3’ replacment vector
that introduces 1xHA tag into
target gene
Recombinant
DNA reagent
TGGT1_217020 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces 1xHA
tag into target gene
Recombinant
DNA reagent
TGGT1_220100 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces 1xHA
tag into target gene
Recombinant
DNA reagent
TGGT1_223500 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces 1xHA
tag into target gene
Recombinant
DNA reagent
TGGT1_229620 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces 1xHA
tag into target gene
Recombinant
DNA reagent
TGGT1_232600 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_248600 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_258100 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_259710 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_260840 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_263080 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Recombinant
DNA reagent
TGGT1_263400 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_263840 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_265360 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_264040 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
(TgApiCox25)
Recombinant
DNA reagent
TGGT1_275650 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_278250 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_278720 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_286120 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_290460 HA in pgCH This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_297810 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
(TgApiCox30)
Recombinant
DNA reagent
TGGT1_300030 HA in pgCH This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_316900 HA
in pgCH
This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TGGT1_318400 HA in pgCH This paper T. gondii 3’ replacment
vector that introduces
1xHA tag into target gene
Recombinant
DNA reagent
TgApiCox25
5’ sgRNA in
pSAG1::Cas9-U6
This paper pSAG1::Cas9-U6 vector
expressing sgRNA that targets
5’ region of TgApiCox25
Recombinant
DNA reagent
TgApiCox25
3’ sgRNA in
pSAG1::Cas9-U6
This paper pSAG1::Cas9-U6 vector
expressing sgRNA that targets
3’ region of TgApiCox25
Recombinant
DNA reagent
TgCox2a 3’
sgRNA in
pSAG1::Cas9-U6
This paper pSAG1::Cas9-U6 vector
expressing sgRNA that targets
3’ region of TgCox2a
Recombinant
DNA reagent
TgApiCox25
in pUgCTH3
This paper Vector that expresses
TgApiCox25-HA from the
constitutive a-tubulin promoter
Software,
algorithm
Mitochondrial
Matrix Quantitative
Proteome search tool
This paper https://bit.ly/2FySSmU Link to region of ToxoDB
website containing the
T. gondii mitochondrial
proteome search tool
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Parasite culture
T. gondii parasites were passaged in human foreskin fibroblasts (HFF) sourced from the Peter Mac-
Callum Cancer Centre, and were verified mycoplasma-free. Parasites were cultured in Dulbecco’s
Modified Eagle’s Medium, supplemented with 1% (v/v) fetal bovine serum and antibiotics. Where
appropriate, ATc was added to a final concentration of 0.5 mg/ml. Plaque assays were performed as
described previously (van Dooren et al., 2008), with plaque sizes measured using ImageJ.
Plasmid construction and parasite transfection
To generate a T. gondii strain expressing mitochondrial matrix-targeted APEX, we amplified the
coding sequence of monomeric APEX using the primers APEX fwd and APEX rvs
(Supplementary file 4), and the vector pcDNA3-mito-APEX as template (a gift from Alice Ting;
Addgene plasmid # 42607; Martell et al., 2012). The resultant PCR product was digested with AvrII
and NdeI and ligated into equivalent sites of the vector Hsp60L-mDHFR in pBTM3 (Figure 1—figure
supplement 1; (van Dooren et al., 2016). This fuses the mitochondrial targeting sequence of
TgHsp60 to 3x c-myc-tagged APEX. The resultant vector was transfected into RHDhxgprt strain T.
gondii parasites, and selected on phleomycin as described (Messina et al., 1995). To generate a T.
gondii strain expressing a mitochondrial matrix-targeted BirA*, we amplified the coding sequence of
BirA* using the primers BirA* fwd and BirA* rvs (Supplementary file 4), and the vector pBir-
A* 3XHA-LIC-DHFR as template (Chen et al., 2015; a gift from Peter Bradley, University of Califor-
nia Los Angeles). The resultant product was digested with BglII and XbaI and ligated into the BglII
and AvrII sites of pgCM3 (GvD, unpublished). The BirA* 3x c-myc cassette of the resultant vector
was digested with AvrII and NotI and ligated into the equivalent sites of the Hsp60L-mDHFR in
pBTM3 vector. This fuses the mitochondrial targeting sequence of TgHsp60 to 3x c-myc-tagged
BirA*. The resultant vector was transfected into RHDhxgprt strain T. gondii parasites, and selected
on phleomycin.
For localizing candidate mitochondrial proteins from the proteome (including TgApiCox25 and
TgApiCox30), we numbered proteins in the dataset and used a random number generator to select
proteins from the list to localise. We excluded any proteins for which the localisation was known or
suspected. We then amplified the 3’ region of 27 target genes using the primers listed in
Supplementary file 4. We digested resultant PCR products with enzymes suitable for subsequent
ligation into the SpeI, BglII and/or AvrII sites of the vector pgCH (Figure 3—figure supplement 1;
Rajendran et al., 2017), as outlined in Supplementary file 4. The resulting vector was linearized
with an enzyme that cut once in the flanking sequence, transfected into TATi/Dku80 strain parasites
(Sheiner et al., 2011), and selected on chloramphenicol as described (Striepen and Soldati, 2007).
The resultant parasite strains have a 1xHA tag fused to the 3’ end of the open reading frame of the
target gene, enabling subsequent localisation of the target protein by immunofluorescence assays.
To introduce an ATc-regulated promoter into the TgApiCox25 locus, we generated a vector
expressing a sgRNA targeting the region around the start codon of TgApiCox25. To do this, we
modified the vector pSAG1::Cas9-U6::sgUPRT (Addgene plasmid # 54467; Shen et al., 2014) using
Q5 site-directed mutagenesis (New England Biolabs) as described previously (Shen et al., 2014).
For site-directed mutagenesis, we used the primers ApiCox25 5’ CRISPR fwd and the universal
reverse primer (Supplementary file 4). We also PCR amplified the ATc-regulated promoter plus a
‘spacer’ region consisting of part of the T. gondii DHFR open reading frame and 3’ UTR using the
pPR2-HA3 vector (Katris et al., 2014) as template and the primers ApiCox25 5’ reg fwd and Api-
Cox25 5’ reg rvs (Supplementary file 4), which each contain 50 bp of sequence specific for the TgA-
piCox25 locus. The sgRNA expressing vector, which also expressed GFP-tagged Cas9, was co-
transfected into TATi/Dku80 strain parasites along with the ATc-regulatable promoter as described
(Striepen and Soldati, 2007). GFP-positive parasites were selected and cloned 3 days following
transfection. Clones were screened for successful integration of the ATc-regulatable promoter using
the primers ApiCox25 5’ screen fwd and ApiCox25 screen rvs, or t7s4 screen fwd and ApiCox25
screen rvs (Supplementary file 4).
To generate a vector that constitutively expressed TgApiCox25 for complementing the rTgApi-
Cox25 mutant, we PCR amplified the TgApiCox25 open reading frame with the primers ApiCox25
comp fwd and ApiCox25 comp rvs (Supplementary file 4). We digested the resulting PCR product
with BamHI and AvrII and ligated this into the BglII and AvrII sites of the vector pUgCTH3 (Figure 5—
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figure supplement 4; Rajendran et al., 2017). The resulting vector was linearized with MfeI, trans-
fected into rTgApiCox25 parasites, and selected on chloramphenicol as described (Striepen and
Soldati, 2007).
To FLAG tag the native locus of TgCox2a, we generated a vector expressing a sgRNA targeting
the region around the stop codon of TgCox2a. To do this, we modified the pSAG1::Cas9-U6::
sgUPRT vector using Q5 mutagenesis with the primer Cox2a 3’rep CRISPR fwd and the Universal
Reverse primer (Supplementary file 4). We also amplified a FLAG tag containing 50 bp of flanking
sequence either side of the TgCox2a stop codon, using the primers Cox2a 3’ rep fwd and Cox2a 3’
rep rvs, with FLAG tag template synthesized as a gBlock (IDT; Supplementary file 4). We co-trans-
fected the plasmid and PCR product into TgApiCox25-HA or rTgApiCox25-HA strain parasites,
selected GFP positive parasites by flow cytometry 3 days post-transfection, then screened for suc-
cessful integrants using the primers Cox2a 3’ screen fwd and Cox2a 3’ screen rvs
(Supplementary file 4).
To FLAG tag the native locus of TgApiCox25, we generated a vector expressing a sgRNA target-
ing the region around the stop codon of TgApiCox25, modifying the pSAG1::Cas9-U6::sgUPRT vec-
tor using Q5 mutagenesis with the primer ApiCox25 3’rep CRISPR fwd and the Universal Reverse
primer (Supplementary file 4). We also amplified a FLAG tag containing 50 bp of flanking sequence
either side of the TgApiCox25 stop codon, using the primers ApiCox25 3’rep fwd and ApiCox25
3’rep rvs, and the FLAG tag gBlock as template (Supplementary file 4). We co-transfected the plas-
mid and PCR product into TgApiCox30-HA strain parasites, selected GFP positive parasites by flow
cytometry 3 days post-transfection, then screened for successful integrants using the primers Api-
Cox25 3’rep screen fwd and TgApiCox25 screen rvs (Supplementary file 4).
Synthesis of biotin-phenol
Biotin phenol was synthesised as described previously (Rhee et al., 2013). 50 mg/ml biotin (Sigma)
was slowly mixed with 1.1 equivalents of 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
(Sigma) and 3.0 equivalents of N,N-diisopropylethylamine (Sigma). The mixture was stirred for 10
min at room temperature, then 1.0 equivalent of tyramine (Sigma) was added slowly. The resulting
solution was stirred overnight at room temperature. The synthesised biotin-phenol was purified from
the unreacted material with a Reveleris flash chromatography system (Grace, MD, USA) and a C18-
WP 4 g column, using an acetonitrile/water gradient. Eluting compounds were monitored with a UV
detector (220 nm, 278 nm, and 350 nm) and an evaporative light scattering detector (ELSD) coupled
to the flash chromatography system. The eluted biotin-phenol in acetonitrile/water mixture was
freeze-dried and reconstituted in dimethyl sulfoxide at a final concentration of 200 mM. The purity
of biotin-phenol was confirmed by ultra-high performance liquid chromatography (UHPLC, Dionex).
Biotinylation approaches
For biotin-phenol labelling, freshly egressed wild type or mtAPEX-expressing parasites were resus-
pended in parasite growth medium. Biotin-phenol was added to the parasites at final concentration
of 1 mM, and parasites were incubated at 37˚C for 1 hr. Biotinylation was initiated by the addition of
1 mM H2O2 for 45 s, and halted by centrifuging cells at 12,000 g for 30 s. The medium was removed,
and parasite cells were washed three times in quenching solution (10 mM sodium azide, 10 mM
sodium ascorbate, and 5 mM Trolox in phosphate-buffered saline (PBS)), and once in PBS. Cell pel-
lets were stored at  80˚C until further processing.
For biotin-labelling, host cells were infected with wild type or mtBirA*-expressing parasites. Biotin
was added to infected host cells ~ 48 hr after infection, to a final concentration of 1 mM. Infected
host cells were cultured for a further 24 hr, during which time they naturally egressed from host cells.
Parasites were harvested by centrifugation at 1500 g and washed 3 times in PBS. Cell pellets were
stored at  80˚C until further processing.
Biotin treated parasite pellets were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM
Tris, 150 mM NaCl, 0.1% (w/v) SDS, 0.5% (w/v) sodium deoxycholate, 1% (v/v) Triton X-100, Com-
plete protease cocktail [Roche]) for 30 min on ice. Biotin-phenol treated parasite pellets were lysed
in RIPA buffer containing quenching agents (10 mM sodium azide, 10 mM sodium ascorbate, and 5
mM Trolox). Three independent lysate pools of WT parasites treated with biotin-phenol and H2O2,
mtAPEX-expressing parasites treated with biotin-phenol and H2O2, WT parasites treated with biotin,
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and mtBirA*-expressing parasites treated with biotin were generated, and protein concentration
was quantified using Bradford reagent (Sigma).
For enrichment of biotinylated proteins with streptavidin beads, 8 mg of protein from each pool
was diluted with RIPA buffer to reach 1.8 ml total volume. 223 ml of streptavidin-conjugated mag-
netic beads (Thermo Scientific) per pool was dispensed in 2 ml microcentrifuge tubes. A magnabind
magnet (Thermo Scientific) was used to separate beads from the buffer solution. Beads were washed
three times in RIPA buffer, and incubated with the corresponding lysate pools for 1 hr at room tem-
perature with gentle rotation. The beads were then washed three times in RIPA buffer, once with
2 M urea in 10 mM Tris-HCl pH 8.0, and a further three times in RIPA buffer. The resin-bound pro-
teins were treated with reducing solution (10 mM DTT in 100 mM ammonium bicarbonate) for 30
min at 56˚C. The reducing solution was removed, and replaced with alkylation solution (55 mM
iodoacetamide in 100 mM ammonium bicarbonate) and incubated at room temperature in the dark
for 45 min. The alkylation solution was then removed, and the beads were washed in 50 mM ammo-
nium bicarbonate for 15 min with gentle agitation. The ammonium bicarbonate solution was
removed, and samples treated with 20 ng/ml sequencing grade trypsin (Promega) overnight (18 hr)
at 37˚C. The next day, the supernatant was collected and beads were further treated with 10% (v/v)
formic acid, and incubated for 15 min at 37˚C.
The volume of peptide filtrates was reduced to ~12 ml in a centrifugal evaporator. Zip tips con-
taining 0.6 ml C18 resin (Millipore) were washed with 10 ml methanol, and 10 ml 0.1% (v/v) formic
acid. The digested peptides were loaded onto the tips by pipetting the peptide solutions 10 times.
The tips were then washed with 10 ml 0.1% (v/v) formic acid twice, and the peptides were eluted into
Chromacol 03-FISV vials with conical 300 ml inserts using 50% acetonitrile/0.1% formic acid (v/v), and
dried in a vacuum concentrator.
MS analysis was performed on a Q-Exactive Classic mass spectrometer as previously described
(Delconte et al., 2016). Raw files consisting of high-resolution MS/MS spectra were processed with
MaxQuant (version 1.5.2.8) for feature detection and protein identification using the Andromeda
search engine (Cox et al., 2011). Extracted peak lists were searched against the UniProtKB/Swiss-
Prot Homo sapiens and Toxoplasma gondii ME49 (ToxoDB-12.0) databases and a separate reverse
decoy database to empirically assess the false discovery rate (FDR) using strict trypsin specificity
allowing up to three missed cleavages. The minimum required peptide length was set to seven
amino acids. Modifications: Carbamidomethylation of Cys was set as a fixed modification, while
N-acetylation of proteins and oxidation of Met were set as variable modifications. The mass toler-
ance for precursor ions and fragment ions were 20 ppm and 0.5 Da, respectively. The ‘match
between runs’ option in MaxQuant was used to transfer identifications made between runs on the
basis of matching precursors with high mass accuracy (Cox and Mann, 2008). PSM and protein iden-
tifications were filtered using a target-decoy approach at a false discovery rate (FDR) of 1%.
Quantitative proteomics pipeline
Statistically-relevant protein expression changes were identified using a custom pipeline as previ-
ously described (Delconte et al., 2016). Probability values were corrected for multiple testing using
Benjamini–Hochberg method. Cut-off lines with the function y= -log10(0.05) + c/(x-x0)
(Keilhauer et al., 2015) were introduced to identify significantly enriched proteins. c was set to 0.2
while x0 was set to one representing proteins that are differentially expressed within 1 or two stan-
dard deviations.
Bioinformatic analyses of data
Homologs of T. gondii mitochondrial proteome proteins were identified in the apicomplexan para-
sites P. falciparum (strain 3D7), C. parvum and B. bovis, and the chromerid V. brassicaformis,
through reciprocal Basic Local Alignment Search Tool (BLAST) searches. T. gondii mitochondrial pro-
teome proteins were used as query sequences in initial searches using target protein databases from
relevant EuPathDB websites (http://PlasmoDB.org– P. falciparum; http://PiroplasmaDB.org – Babesia
bovis; http://CryptoDB.org – Cryptosporidium parvum and Vitrella brassicaformis;
Aurrecoechea et al., 2013). Hits from the initial BLAST search were queried in reciprocal BLAST
searches against the T. gondii genome database (http://toxodb.org), regardless of the score or
E-value obtained. Hits that returned the corresponding T. gondii protein that was originally searched
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against were considered as a homolog. Expect (E) values obtained from the initial BLAST search and
the reciprocal BLAST search were recorded (Supplementary file 1). Homologs of proteins identified
in the purified ApiCox25 complex were identified using the profile hidden Markov model search tool
HMMER (https://www.ebi.ac.uk/Tools/hmmer/).
Ortholog grouping for each protein was obtained from ToxoDB. Each ortholog group was
assessed for the presence of ortholog proteins in other eukaryotic organisms based on the phyletic
information available on http://OrthoMCL.org (Chen et al., 2006). Information of ortholog grouping
for the entire genome of the chromerid V. brassicaformis were sourced from CryptoDB, and were
subsequently compared to the ortholog groups identified for the T. gondii mitochondrial proteome.
HHPRED predictions were performed using the MPI Bioinformatics Toolkit website (https://toolkit.
tuebingen.mpg.de/#/tools/hhpred; Zimmermann et al., 2018).
The presence of predicted mitochondrial targeting peptides was assessed using MitoProt
(Claros and Vincens, 1996), with the probability of export into the mitochondria recorded
(Supplementary file 1). Metabolic pathway enrichment was assessed using the Metabolic Pathway
search tool on ToxoDB, using a p value cut-off of <0.05.
Immunofluorescence assays and microscopy
IFAs were performed as described previously (van Dooren et al., 2008). Primary antibodies used
were mouse anti-c-myc (1:200 dilution; Santa Cruz clone 9E10), rat anti-HA (1:200 dilution; Sigma
clone 3F10), and rabbit anti-Tom40 (1:2000 dilution; van Dooren et al., 2016). Secondary antibodies
used were goat anti-mouse Alexa Fluor 488 (1:500 dilution; Life Technologies), goat anti-rat Alexa
Fluor 488 (1:100 to 1:500 dilution; Life Technologies), goat anti-rat CF 488A (1:100 to 1:500 dilution;
Sigma), and goat anti-rabbit Alexa Fluor 546 (1:500 dilution; Life Technologies). Biotinylation was
performed as outlined for the proteomics, except that mtAPEX samples were incubated in H2O2 for
1 min. For visualizing biotinylated proteins, we used Oregon Green-conjugated avidin (1:1000 dilu-
tion; Life Technologies). Images were acquired on a DeltaVision Elite deconvolution microscope (GE
Healthcare) fitted with a 100X UPlanSApo oil immersion objective lens (NA 1.40). Images were
deconvolved and adjusted for contrast and brightness using SoftWoRx Suite 2.0 software, and sub-
sequently processed using Adobe Illustrator.
Immunoprecipitations
Immunoprecipitations were performed as described previously (van Dooren et al., 2016), except
that parasite samples were solubilized in 1% (v/v) Triton X-100. HA-tagged proteins were purified
using anti-HA affinity matrix (Sigma; rat anti-HA clone 3F10 antibodies) and FLAG-tagged proteins
were purified using anti-FLAG M2 affinity gel (Sigma; mouse anti-FLAG clone M2 antibodies). For
mass spectrometry sample preparation, anti-HA beads bound with HA-tagged protein complexes
were frozen at  80˚C for 1 hr, then eluted at 37˚C in 0.2 M glycine containing 1% (v/v) Triton X-100
(pH 2.3). Samples were neutralized in ammonium bicarbonate, then extracted in chloroform:metha-
nol as described (Pankow et al., 2016). After extraction, the pellets were dried and stored at  80˚C
before mass spectrometry analysis.
For the analysis, the protein pellets were dissolved in digestion buffer (8 M urea, 50 mM
NH4HCO3, 10 mM dithiothreitol) and incubated at 25˚C for 5 hr. Following incubation, iodoaceta-
mide was added to a final concentration of 55 mM to alkylate thiol groups and incubated for 35 min
at 20˚C in the dark. The alkylated protein preparations were diluted to 1 M urea in 25 mM ammo-
nium bicarbonate (pH 8.5) and sequencing-grade trypsin (Promega) was added to a ratio of 1:50 (w/
w) to the samples. The reaction was incubated for 16 hr at 37˚C. The digests were acidified with 1%
(v/v) trifluoroacetic acid (TFA), dried in a SpeedVac centrifuge followed by a desalting step on SDB-
XC StageTips (Empore, SDB-XC reversed-phase material, 3M, St. Paul, USA). Briefly, the digested
proteins were resuspended in 100 mL of 1% (v/v) formic acid and centrifuged at 14 000 rpm for 2
min. The solid-phase extraction was performed according to (Rappsilber et al., 2007) with the fol-
lowing modifications: the membrane was conditioned with 50 mL of 80% (v/v) acetonitrile, 0.1% (w/v)
TFA, and then washed with 50 mL of 0.1% TFA before the tryptic peptides were bound to the mem-
brane. The bound peptides were eluted by 50 mL 80% (v/v) acetonitrile, 0.1% (w/v) TFA, and dried in
a SpeedVac centrifuge.
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Peptides reconstituted in 0.1% TFA and 2% acetonitrile (ACN) were loaded using a Thermo Scien-
tific UltiMate 3000 RSLCnano system onto a trap column (C18 PepMap 300 mm ID 2 cm trapping
column, Thermo Fisher Scientific) at 15 ml/min for six minutes. The valve was then switched to allow
the precolumn to be in line with the analytical column (Vydac MS C18, 3 mm, 300 A˚ and 75 mm
ID 25 cm, Grace Pty. Ltd.). The separation of peptides was performed at 300 nl/min at 45˚C using
a linear ACN gradient of buffer A (water with 0.1% formic acid, 2% ACN) and buffer B (water with
0.1% formic acid, 80% ACN), starting at 5% buffer B to 45% over 105 min, then 95% B for five
minutes followed by an equilibration step of 15 min (water with 0.1% formic acid, 2% ACN). Data
were collected on an Orbitrap Elite (Thermo Fisher Scientific) in Data Dependent Acquisition mode
using m/z 300 – 1500 as MS scan range, CID MS/MS spectra were collected for the 10 most intense
ions at a normalized collision energy of 35% and an isolation width of 2.0 m/z. Dynamic exclusion
parameters were set as follows: repeat count 1, duration 90 s, the exclusion list size was set at 500
with early expiration disabled. Other instrument parameters for the Orbitrap were the following: MS
scan at 120 000 resolution, maximum injection time 150 ms, AGC target 1  106 for a maximum
injection time of 75 ms with AGT target of 5000.
The spectra obtained from the instrument were used to search against the UniProt TOXGV (T.
gondii) database together with common contaminants using the Mascot search engine (Matrix Sci-
ence Ltd., London, UK). Briefly, carbamidomethylation of cysteines was set as a fixed modification,
acetylation of protein N-termini and methionine oxidation was included as variable modifications.
Precursor mass tolerance was 10 ppm, product ions were searched at 0.5 Da tolerances, maximum
of 2 missed trypsin cleavages, minimum peptide length defined at 6, maximum peptide length 144,
and peptide spectral matches were validated using Percolator based on q-values at a 1% false dis-
covery rate.
SDS-PAGE, Blue Native-PAGE and immuno/affinity-blotting
SDS-PAGE and protein blotting were performed as described previously (van Dooren et al., 2008),
except that membranes used for neutravidin blotting were blocked with 3% (w/v) bovine serum albu-
min (BSA). Blue native PAGE was performed using the NativePAGE system (Thermo Scientific) as
described previously (van Dooren et al., 2016). Blots were probed with antibodies against mouse
anti-c-myc (1:500 dilution; Santa Cruz clone 9E10), rabbit anti-Hsp60 (1:1000 dilution; Tonkin et al.,
2004), rabbit anti-T. gondii cytochrome c (1:500 dilution; E.T. and G.v.D., unpublished), rat anti-HA
(1:500 to 1:1000 dilution; Sigma clone 3F10), mouse anti-FLAG (1:500 to 1:2000 dilution; Sigma
clone M2), and rabbit anti-AtpB (1:500; Agrisera, catalog number AS05 085). Horseradish peroxidase
(HRP)-conjugated anti-mouse, anti-rat and anti-rabbit antibodies (Santa Cruz) were used at 1:5000
dilution. For probing for mouse antibodies on immunoprecipitation western blots, HRP-conjugated
anti-mouse TrueBlot ULTRA antibodies (eBioscience) were used at 1:5000 dilution. Neutravidin-HRP
(Life Technologies) was used to detect biotinylated proteins on membranes at 1:10,000 dilution.
Seahorse XFe96 extracellular flux analysis
Wild type (TATi/Dku80) and rTgApiCox25 parasites were grown in the absence of ATc, in the pres-
ence of ATc for 1 – 3 days, or with 100 mM cycloheximide for 1 day. Parasites were filtered through
a 3 mm polycarbonate filter and washed twice in Seahorse XF base medium (Agilent Technologies),
supplemented with 1 mM L-glutamine and 5 mM D-glucose (supplemented base medium), before
resuspension to 1.5  107 cells/ml in the supplemented base medium. 96-well Seahorse culture
plates were coated with 3.5 mg/cm2 of CellTak cell adhesive (Corning) according to the manufac-
turer’s instructions. Briefly, 1 mg/ml CellTak was diluted 1:50 in 0.1 M sodium bicarbonate. 15 ml of
CellTak solution was added to each well of a Seahorse cell culture plate and incubated at RT for 20
mins. The solution was removed and the plate washed twice in sterile water, before drying. 100 ml of
the parasite suspensions (1.5  106 parasites) were seeded into wells of the coated plate, and the
plate was centrifuged at 50 g for 3 min. An additional 75 mL of supplemented base medium was
added to each well following centrifugation. Parasites were kept at 37˚C in a non-CO2 incubator until
the start of experiment. Parasite oxygen consumption rates (OCR) and extracellular acidification
rates (ECAR) were measured using an Agilent Seahorse XFe96 Analyzer at 3 min intervals. To deter-
mine the maximal OCR, parasites were treated with 20 mM oligomycin A, B and C mix (Sigma) to
inhibit ATP synthase, then subsequently treated with 1 mM carbonyl cyanide-4-(trifluoromethoxy)
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phenylhydrazone (FCCP; Sigma). To determine the non-mitochondrial OCR, parasites were treated
with 10 mM antimycin A (Sigma) and 1 mM atovaquone (the minimal concentration that preliminary
experiments indicated is sufficient to maximally inhibit mitochondrial OCR). The mitochondrial OCR
(mOCR) was calculated by subtracting the non-mitochondrial OCR from the basal and maximal OCR
values. A minimum of 4 wells were used for background correction in each assay plate, and 4 – 5
technical replicates were used for each condition. Wells that yielded negative OCR values were
excluded from the final analysis.
Miscellaneous data analysis
XFe96 data were compiled using the Wave Desktop program. Analysis of parasite OCR and ECAR
were performed using the R software environment (Source code 1). Linear mixed-effects models
were fitted to the data, with error between plates and wells (i.e. between and within experiments)
defined as the random effect, and the OCR and ECAR measurements in the different parasite strains
(WT and rTgApiCox25) and the time since ATc-addition defined as the fixed effect. Data from the
TgApiCox25-HA and TgTom40-HA co-immunopreciptation proteomics were analysed in the R soft-
ware environment using the EdgeR package (Source code 2; Robinson and Smyth, 2008). Only
proteins identified in both experimental conditions and each biological replicate were included in
the final analysis. Graphing of the XFe96 and TgApiCox25 proteomic data were performed in Graph-
Pad Prism v. 7.0.
Data availability
The mitochondrial proteome data are available on individual gene pages on the ToxoDB website
(http://toxodb.org), and a ‘Mitochondrial Matrix Quantitative Proteome’ search tool is available in
the proteomics section of ToxoDB (https://bit.ly/2FySSmU). To use the search tool, first select the
experiment that you want to query. ‘Control APEX vs mito APEX’ queries the APEX data, and ‘Con-
trol BirA vs mito BirA’ queries the BirA* data. Next select the direction of the query. To examine
genes that are enriched in the mitochondrial matrix proteomes, select ‘down-regulated’ (i.e. proteins
that are less abundant in control samples than in the mito APEX/BirA* samples). Next select the
desired P value. For our analyses, we utilised a P value of  0.001. Finally, select the desired fold dif-
ference. For our analyses, we utilised a log2 fold change value of    2.5, which corresponds to a
fold change between the experimental and control samples of 5.657 (i.e. 5.657-fold down-
regulated).
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sequence counts. Table 3. List of proteins identified in the RH control and mtBirA* proteomes,
including the ToxoDB accession numbers, the log2 protein ratios, p value, and unique sequence
counts. Table 4. Summary of putative mitochondrial proteins identified in this study. The summary
includes the ToxoDB accession numbers and annotation of proteins identified from the combined
list (colums A and B), proteins identified in both lists (columns D and E), and proteins identified in
the mtAPEX proteome (columns G and H) or mtBirA* (columns J and K) proteomes only. Proteins
highlighted in green were demonstrated by this study to localise to the mitochondrion, while those
highlighted in red did not localise to the mitochondrion. Table 5. Annotated protein list of the T.
gondii mitochondrial proteome, noting the ToxoDB accession number of the corresponding gene,
the protein annotation, mean phenotype score, molecular mass, number of transmembrane
domains, amino acid sequence, MitoFates and MitoProt II prediction scores, the ortholog grouping,
and the accession number of orthologous genes in P. falciparum, C. parvum, B. bovis, V. brassicafor-
mis, and S. cerevisiae based on reciprocal BLAST searches. Homologs identified in S. cerevisiae were
queried against the ‘high confidence’ mitochondrial proteome (Sc mito proteome) described in
(Morgenstern et al., 2017). Table 6. Summary of the OrthoMCL analysis of the T. gondii mitochon-
drial proteome, depicting the gene annotation, mean phenotype score, and the relevant orthology
grouping.
DOI: https://doi.org/10.7554/eLife.38131.019
. Supplementary file 2. Summary of metabolic pathway enrichment in the T. gondii mitochondrial
proteome.
DOI: https://doi.org/10.7554/eLife.38131.020
. Supplementary file 3. Expected mitochondrial proteins and false negatives identified from the T.
gondii mitochondrial proteome. List of proteins identified in the T. gondii mitochondrial proteome
that previous studies have demonstrated or predicted to localize to the mitochondrion, and proteins
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that previous studies have demonstrated do not localize to the mitochondrion. Included are the pro-
tein annotation, the process in which it functions, the proteome in which it was detected, and the
ToxoDB gene ID. Note that natively biotinylated proteins (including the mitochondrially-localized
pyruvate carboxylase; Nitzsche et al., 2017) were excluded from these analyses because of their
biased (i.e. APEX and BirA*-independent) enrichment in control and experimental conditions. Color
coding: green, predicted mitochondrial protein present in proteome; pink, predicted mitochondrial
protein absent from proteome.
DOI: https://doi.org/10.7554/eLife.38131.021
. Supplementary file 4. List of primers and templates used in this study. Table 1. Primers and tem-
plates used in general cloning. Table 2. Primers used in 3’ replacement localization studies. 3’ frag-
ments of target genes (ToxoDB gene ID) were amplified using the listed forward and reverse
primers. The resulting PCR product was digested and ligated into the vector pgCH as outlined in
the cloning strategy. The final vector was linearized with the indicated restriction enzyme before
transfection.
DOI: https://doi.org/10.7554/eLife.38131.022
. Supplementary file 5. Table 1: List of proteins identified in the TgApiCox25 and TgTom40 immuno-
precipitations. Included is a description of each identified protein, the UniProt accession number,
the predicted molecular mass, the fold change, the normalized total precursor intensity for each bio-
logical replicate, and the Cox or ApiCox designation of the identified protein. Table 2: A list of the
log fold change (logFC) and p values calculated for each protein identified in all replicates of the
TgApiCox25 and TgTom40 immunoprecipitations following EdgeR analysis.
DOI: https://doi.org/10.7554/eLife.38131.023
. Source code 1. R script used in the analysis of the Seahorse XFe96 data.
DOI: https://doi.org/10.7554/eLife.38131.024
. Source code 2. R script used in the analysis of proteomic data from the TgApiCox25 and TgTom40
immunoprecipitations.
DOI: https://doi.org/10.7554/eLife.38131.025
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.38131.026
Data availability
Mitochondrial proteomics data are available in on the ToxoDB website (http://toxodb.org).
The following dataset was generated:
Author(s) Year Dataset title Dataset URL
Database, license,
and accessibility
information
Giel G van Dooren 2018 Mitochondrial Matrix Quantitative
Proteome
https://bit.ly/2FySSmU Publicly available at
ToxoDB (https://
toxodb.org).
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